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Depression frequently co-occurs with substance use disorders, which are a severe 
health and financial burden on our society (Office of National Drug Control Policy, 2011; 
Office of National Drug Control Policy, 2014). This study examined transtheoretical 
model of change (TTM) constructs in individuals with elevated depressive symptoms and 
a comorbid substance use disorder, looking to better understand how the depressive 
symptoms influenced the individuals’ changing substance use behavior.  
This study was conducted at the Substance Abuse Research Center in the 
University of Texas Mental Sciences Institute in Houston, Texas in 2006.  Participants 
(N=138) who met the DSM-IV criteria for cocaine use or dependence disorder were 
recruited. The sample was 72.2% Black, 19.4% White, and 8.3% Latino.  Participants 
were in one of two treatment conditions for cocaine use disorder: 1) a TTM group 
intervention, modified for cocaine users, or 2) the control condition, an education and 
advice group. Data on substance use, TTM constructs, symptoms of behavioral health 
disorders, and other factors were collected at the beginning of the intervention, the end of 
 viii 
the intervention, and three months post-intervention.  Profile analysis and general linear 
model (GLM) analysis of variance (ANOVA) were used to examine the hypotheses that 
cocaine users with elevated depressive symptoms would endorse the TTM constructs 
differently than the nondepressed participants, especially the processes of change 
constructs, but would reduce their cocaine use the same amount as the nondepressed 
users.  
This study found that participants with elevated depressive symptoms were as 
successful as nondepressed participants in reducing their cocaine use after treatment.  
However, participants with elevated depressive symptoms engaged with the TTM 
variables differently compared to nondepressed participants, especially the processes of 
change and temptation variables.  The behavioral processes of change were significantly 
lower before treatment and the experiential processes of change were significantly higher 
after treatment compared to nondepressed participants.  Temptation was higher in 
participants with elevated depressive symptoms compared to nondepressed participants 
and lower temptation in participants with elevated depressive symptoms was linked to 
more successful reduction in cocaine use.  These findings indicate that temptation and the 
processes of change are important variables to target in treatment of substance use 
disorders in adults with elevated depressive symptoms. 
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 Substance abuse is a major health concern and burden to the economy.  Deaths 
directly related to drugs, such as accidental overdoses, have more than doubled in the last 
twenty years to 40,000 people (Office of National Drug Control Policy, 2011).  Illicit 
drug use cost the economy almost $200 billion in 2007 through lost productivity, 
healthcare costs, and criminal justice costs (Office of National Drug Control Policy, 
2014).  It is imperative that we develop effective substance use interventions in order to 
address this pressing issue.  
A substance use disorder occurs when use of the substance continues despite 
significant impairment in personal or work life (American Psychiatric Association, 2013).  
Stimulant use disorder is one type of substance use disorder.  Cocaine, the substance that 
is the focus of the intervention examined in this study, is a type of stimulant that creates 
an immediate and intense euphoric response (NIDA, n.d.).  As tolerance increases, 
frequent cocaine users must consume greater and greater amounts of cocaine to achieve 
the same “high,” which makes cocaine a highly addictive substance (NIDA, n.d.).  
Often adults with stimulant use, similar to other substance use disorders, have 
depression as well.  Comorbidity/dual diagnosis is associated with worse outcomes, 
including increased suicidal ideation, poorer social functioning, and increased rates of 
health care utilization compared with those either diagnosed with depression or substance 
use disorder (Sullivan, Fiellin, & O'Connor, 2005).  It is also linked to worse mental and 
physical health outcomes pre- and post-treatment, and worse social and behavioral 




(Burns, Teesson, & O’Neill, 2005; Degenhardt, Hall, & Lynskey, 2001; Grant et al., 
2004; Mills et al., 2009; Pettinati, O’Brien, & Dundon, 2013).  Numerous treatment 
studies show that although all participants improve in reducing alcohol consumption, 
including those who are dually diagnosed, those with comorbid depression begin 
treatment with a higher level of alcohol consumption and, as a result, continue to use 
substances at a higher rate after intervention (Burns, Teesson, & O’Neill, 2005; 
Degenhardt, Hall, & Lynskey, 2001; Grant et al., 2004; Mills et al., 2009; Pettinati, 
O’Brien, & Dundon, 2013).  The complex interaction between depression and substance 
use, particularly cocaine, and how it pertains to effective intervention, is not well 
understood. There is even less research on effective intervention with populations that 
have comorbid stimulant use disorder and depression diagnoses.  
One of the most prominent frameworks for understanding the substance use 
interventions and behavior change is the transtheoretical model of behavioral change 
(TTM; Prochaska & DiClemente, 1984).  This comprehensive biopsychosocial model, 
integrated from various fields’ existing models and concepts of change, conceptualizes 
change as a dynamic rather than static process (Velicer, Prochaska, Fava, Norman, & 
Redding, 1998).  Variables important to the TTM are the stages of change, decisional 
balance, temptation, confidence, and the experiential and behavioral processes.  A large 
body of research supports each of these constructs as part of the change process in 
substance use.  The stages of change, for example, describe the development of one’s 
change process, which are characterized by their readiness to change (Marshall & Biddle, 
2001; Prochaska, Velicer, DiClemente, & Fava, 1988).  The stages are not linear, 




process (Prochaska, DiClemente, & Norcross, 1992).  The experiential and behavioral 
processes of change are considered the engines of change, propelling individuals through 
the stages of change (Velasquez, Crouch, Stephens, & DiClemente, 2016).  The processes 
have strong cognitive, affective, and behavioral components that one experiences in order 
to make lasting behavioral change (Stotts, DiClemente, Carbonari, & Mullen, 1996; 
Velasquez, Crouch, Stephens, & DiClemente, 2016).   
There is little research on the influence of depressive symptoms on the reduction 
of substance use and other wellness outcomes through the TTM variables (Blume, 
Schmaling, & Marlat, 2001).  As many symptoms of depression influence behavioral 
change, adults with those symptoms may engage in TTM variables differently than 
people who are not depressed.  Current research shows conflicting results as to how 
depressed adults compare to nondepressed adults on many of the TTM variables when 
changing substance use (Blume, Schmaling, & Marlat, 2001; Smith & Tran, 2007; Tsoh 
& Hall, 2004). Furthermore, there is no research on how depressed adults compare to 
nondepressed adults on each of the ten experiential and behavioral processes of change, 
which are constructs within the TTM.  As the processes of change have cognitive, 
affective, and behavioral components, all strongly associated with depression, adults with 
elevated depressive symptoms may navigate these processes differently than 
nondepressed adults.  A better understanding of how depressive symptoms influence 
adults’ engagement with the TTM variables in substance use interventions would allow 
these interventions to be targeted to dually diagnosed adults, improving the outcomes for 




This study investigated whether adult stimulant users with elevated depressive 
symptoms seeking to change their behavior were different compared with nondepressed 
substance users on the TTM variables, whether they reduced their substance use as much 
as nondepressed substance users, and how adults with elevated depressive symptoms who 
were successful in reducing substance use compared to those who were not successful.  
These questions were examined using extant data from a feasibility study completed in 
2006 by Dr. Mary Velasquez and colleagues on a National Institutes of Health (NIH) 
funded TTM-based intervention for substance use (see Appendix A).  Participants 
(N=138) who met the DSM-IV criteria for cocaine use or dependence disorder were 
placed into groups that were randomly assigned to one of two treatment conditions: 1) a 
TTM group intervention, modified for cocaine users, or 2) an education and advice 
group.  The sample was 72.2% Black, 19.4% White, and 8.3% Latino.  Data on substance 
use, TTM constructs, symptoms of behavioral health disorders, and other factors were 
collected at the beginning of the intervention, the end of the intervention, and three 







Substance abuse in the United States is a major health and economic concern. The 
Centers for Disease Control and Prevention reported that in 2010 alone more than 40,000 
people died of directly drug-related deaths, such as accidental overdose, which is more 
than double the number of drug-related deaths in 1999 (Office of National Drug Control 
Policy, 2014). Furthermore, the National Drug Intelligence Center estimated that illicit 
drug use cost the US economy more than $193 billion in 2007 through lost productivity, 
healthcare costs, and criminal justice costs (Office of National Drug Control Policy, 
2011).  These numbers place substance abuse among the major health problems facing 
the US and suggest that focused intervention is needed to address and ameliorate it.  
Substance Use Disorders 
Substance use disorders, according to the Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition  (DSM-V), occur when an individual continues use of 
alcohol and/or drugs despite significant impairment in personal or work life (American 
Psychiatric Association, 2013).  This impairment may include health concerns, disability, 
and an inability to maintain responsibilities at home or at work. There is a wide range of 
severity of substance use disorders, from mild to severe (American Psychiatric 
Association, 2013).  Multiple studies show that genetic factors influence 40-60% of an 
individual’s risk for addiction (Pace & Samet, 2016).   Other factors that may influence 
the development of a substance use disorder include environmental influences and 




Stimulant use disorder is one type of substance use disorder.  Stimulants have a 
strong physiological impact, increasing alertness, attention, and energy, as well as 
increasing heart rate, respiration, and blood pressure (National Institute on Drug Abuse 
[NIDA], n.d.). Cocaine is a powerful stimulant with highly addictive properties (NIDA, 
n.d.).  Derived from the coca plant grown in South America, it is used medically for a 
few specific purposes but is otherwise illegal in the United States.  Generally sold as a 
white powder, cocaine is snorted, rubbed into the gums, or injected intravenously.  It is 
also sold as a rock crystal that is smoked, referred to as crack (NIDA, n.d.).  
Cocaine’s highly addictive properties are attributable to its powerful influence on 
the brain’s reward pathways.  Cocaine increases the level of dopamine in these pathways, 
a neurotransmitter that is generally released in response to a pleasurable stimulus, such as 
eating (NIDA, n.d.).  With cocaine use and the subsequent release of dopamine by the 
neuron into the synapse, dopamine’s reuptake is blocked (NIDA, n.d.).  This increased 
level of dopamine between the cells leads to a greater sense of reward, leading to the 
euphoria that cocaine users experience.  However, the reward circuit in the brain quickly 
accustoms to the higher levels of dopamine, requiring the user to ingest a continually 
greater amount for the same “high” (NIDA, n.d.).   
Initial effects of cocaine are euphoria, high energy, confidence, mental alertness, 
irritability, paranoia, and hypersensitivity to sight, sound, and touch (American 
Psychiatric Association, 2013; NIDA, n.d.).  These effects appear instantly after using 
cocaine and wear off quickly, sometimes within a few minutes.  Some people report that 
while using small amounts of cocaine they are still able to carry out everyday tasks, but 




n.d.).  Long-term effects of cocaine include malnourishment, movement disorders (such 
as Parkinson’s disease), and severe paranoia, including auditory hallucinations.  Further 
risks of long-time stimulant use include sexual dysfunction, chaotic behavior, social 
isolation, and aggressive behavior (American Psychiatric Association, 2013). There are 
other long-term health risks, depending on how the cocaine is consumed.  If snorted, risks 
include loss of sense of smell, frequent nosebleeds, nasal septal perforations, and 
problems swallowing.  If consumed by mouth, a person may experience severe bowel 
decay because of reduced blood flow.  If consumed through needle injection, the 
individual is at higher risk for blood-borne infectious diseases, such as HIV and hepatitis 
B and C (NIDA, n.d.).  Cocaine users are at risk for a fatal overdose, especially when 
used in combination with alcohol and other substances.  Consumption of cocaine at high 
doses can lead to long-term heart dysfunction, heart attack, stroke, or seizure (NIDA, 
n.d.). 
Because of cocaine’s influence on the brain’s reward circuit, cocaine users are at 
high risk of becoming addicted, signaled by tolerance, withdrawal, and continued use 
despite detrimental effects in multiple aspects of life, such as financial, social, 
occupational, and health.  Attempts to reduce cocaine use will likely be accompanied by 
strongly unpleasant withdrawal symptoms.  As the cocaine user’s brain has become 
accustomed to higher levels of dopamine, when users stop consuming cocaine, the lower 
levels of dopamine lead to symptoms such as depression, fatigue, and slower thinking 
(NIDA, n.d.). 
The many risks to health, impairment of daily life, and cost to individuals and the 




individuals.  One challenge facing substance use intervention is comorbid depression.  
People with substance use disorders often have depression as well, and studies show that 
those with both disorders have more severe symptomatology and struggle more in 
maintaining wellness (Pettinati, O’Brien, & Dundon, 2013).   
Depression 
Depression is a common medical condition, affecting an estimated 16 million 
adults yearly in the United States (National Institute of Mental Health [NIMH], n.d.; 
National Alliance of Mental Illness [NAMI], n.d.). Adults with major depressive disorder 
incurred an economic cost of $210.5 billion in 2010 including direct costs, suicide-related 
costs, and workplace costs (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015).  
Considering inflation, this is an increase of 21.5% from 2005 (Greenberg et al., 2015).  
The most devastating impact of depression, which occurs especially when depression is 
untreated, is suicide.  Suicide is the tenth leading cause of death in the United States, 
accounting for at least 41,000 deaths in 2013 (CDC, n.d.).  
Like substance use disorder, depression has a negative impact on daily 
functioning in various areas of activity such as at work and in an individual’s personal 
life.  Depression has a strong genetic component, with heritability of depression up to 
40% (American Psychiatric Association, 2013).  Other risk factors include substance use, 
trauma or a traumatic event, and chronic stress or a stressful episode (American 
Psychiatric Association, 2013).  Women are more likely than men to be depressed 
(American Psychiatric Association, 2013). 
Individuals who are depressed experience sadness and/or loss of interest, as well 




Association, 2013).  Other symptoms include feelings of guilt, worthlessness, 
hopelessness, and pessimism; thoughts of death or suicide; trouble concentrating and 
making decisions; agitation or moving slowly; changes in sleep and appetite; aches and 
pains; and fatigue (American Psychiatric Association, 2013).   These symptoms are 
implicated in poorer outcomes for comorbid physical and mental health conditions, such 
as substance use disorders (American Psychiatric Association, 2013).  
There is a high prevalence of comorbid depression and substance use disorders 
(Baker, Thornton, Hiles, Hides, & Lubman, 2012).  While there is little information 
specifically evaluating comorbid depression and cocaine use disorder, many studies have 
examined comorbid depressive disorders and substance use disorders. Based on two 
large-scale epidemiological studies in the United States, adults with major depressive 
disorder have a lifetime prevalence of 40.3% for alcohol use disorder and 17.2% for a 
drug use disorder (Pettinati, O’Brien, & Dundon, 2013).   Adults with alcohol 
dependence are three to four times more likely than the general population to have a 
mood or anxiety disorder (Burns, Teesson, & O’Neill, 2005; Degenhardt, Hall, & 
Lynskey, 2001; Grant et al., 2004; Pettinati, O’Brien, & Dundon, 2013).  In treatment 
settings, this rate is even higher, with one study finding that those seeking treatment for 
alcohol use disorder had comorbid depression at a rate of 32.8% (Grant et al., 2004).   
These co-occurring disorders are associated with multiple negative outcomes.  
Researchers have found that the symptoms of the individual disorders are more severe 
when co-occurring, such as increased suicidal ideation, poorer social functioning, and 
increased rates of health care utilization (Sullivan, Fiellin, & O'Connor, 2005).  Multiple 




alcohol consumption, including those with comorbid conditions, those with comorbid 
conditions have a higher level of alcohol consumption initially and after treatment, worse 
mental and physical health outcomes, and worse social and behavioral functioning in 
long-term follow-ups (Mills et al., 2009).  Studies on smoking cessation show that adults 
who have major depressive disorder have higher rates of smoking and struggle more to 
quit, an effect that is stronger with severe depression (Strong et al., 2012).   In sum, when 
an adult has these co-occurring disorders, it is more difficult to maintain wellness than for 
individuals with just one of these disorders (Penberthy, Hook, Hettema, Ferrell-Carnahan, 
& Ingersoll, 2013). 
Our current understanding of the complex interaction between these disorders is 
limited. Depressive symptoms often reduce following abstinence from substance abuse.  
In these cases, depression is considered secondary to the substance use disorder and 
requires no further treatment (Burns, Teesson, & O’Neill, 2005).  However, Grant et al. 
(2004) found that a significant number of depressive disorders are independent of 
substance use, and thus require treatment.  Furthermore, substance use is often used as a 
negative coping strategy for dealing with depressive symptoms.  Moderate to severe 
drinking can reduce the effect of antidepressants, making them ineffective in treating 
depression, increasing side effects of the medication, and even reducing treatment 
adherence (Worthington et al., 1996).  As an added complication, excessive drinking, 
especially binge drinking, has been found to be followed by depressive symptoms (Baker 
et al., 2014). 
As the interaction between substance use disorders and depression is complicated 




understanding of the impact of depression on the treatment of substance abuse is needed. 
With this understanding comes the hope of improving long-term health outcomes for 
adults with these comorbid disorders.  Interventions addressing substance abuse must 
take into account the powerful impact that comorbid depression can have on changing 
behavior, health outcomes, and activities of daily living. 
Interventions for Cocaine Use 
The primary intervention for cocaine use is behavioral, as current medical 
treatments for cocaine use disorder are limited to a vaccine that is not yet Food and Drug 
Administration (FDA) approved (Martinez & Trifilieff, 2014).  While early research on 
this vaccine shows promise to aid in abstinence maintenance, studies thus far have found 
that it does not help those who are initially quitting cocaine use.  Because the vaccine 
binds to consumed cocaine, limiting the body’s ability to feel its euphoric effects, but 
does not change the addiction to cocaine, addicted users generally use more cocaine in 
order to counteract the effect of the vaccine (Martinez & Trifilieff, 2014).  Thus, even 
with the vaccine, concurrent behavioral intervention is suggested (NIDA, 2015).  As only 
20% of the population is ready to actively make a change in their detrimental behavior, 
an intervention that is oriented to address people at various levels of readiness to change 
is necessary (Miller & Rollnick, 2013).  The best-known model of this type is the 
transtheoretical model of behavior change. 
Transtheoretical Model of Behavior Change 
The transtheoretical model of behavior change (TTM) was initially developed by 
Prochaska and DiClemente during the 1980s (Prochaska & DiClemente, 1984). This 




and ideas of change from various fields, hence the name “transtheoretical” (Velicer, 
Prochaska, Fava, Norman, & Redding, 1998).  This theory presents behavior change as a 
dynamic rather than static process, providing a framework for understanding, measuring, 
and intervening in behavior change throughout the change process, not only when the 
person is actively pursuing change (Marshall & Biddle, 2001; Velicer et al., 1998).  
 Stages of change. The research shows that people making changes in their 
behavior move through various stages of the change process, characterized by their 
readiness to change (Marshall & Biddle, 2001).  The stages of change in the TTM 
provide a temporal and developmental understanding of behavioral change (Prochaska, 
Velicer, DiClemente, & Fava, 1988). As these stages are not linear, movement between 
the stages occurs, including relapse (Prochaska, DiClemente, & Norcross, 1992).  These 
stages are precontemplation, contemplation, preparation, action, and maintenance 
(DiClemente et al., 1991). 
Precontemplation. In the precontemplation stage, people do not have a desire for 
change.  They have no intention of making any steps towards change in the foreseeable 
future, usually described as the next six months.  These individuals may have little to no 
information about why their behavior is harmful or they may have unsuccessfully 
attempted change multiple times in the past and so are discouraged about making any 
future changes.  In other theories, these individuals would be considered the “resistant” 
clients. According to the TTM, individuals with substance use disorders in the 
precontemplation stage are more aware of the reasons against reducing their use rather 
than the reasons for it (DiClemente et al., 1991; Prochaska & Velicer, 1997; Velicer, 




Contemplation.  Individuals in the contemplation stage are thinking about making 
a change, but have made no action towards making a change.  They are aware of the 
benefits of changing their behavior, but are also aware of the cons.  Because of this 
ambivalence, many individuals will remain in this stage for a long time, ruminating on 
their decision and struggling to move forward with making a behavioral change.  
Substance users in the contemplation stage have equal considerations of the pros and 
cons of quitting substance use, leading to rumination and possibly being in this stage for a 
long period of time (DiClemente et al., 1991; Prochaska & Velicer, 1997; Velicer, 
Prochaska, Fava, Norman, & Redding, 1998).   
Preparation.  In this stage, individuals are making plans to change, but have not 
yet begun the change process.  Usually they have made some step towards change, such 
as seeking help from a health care professional, joining a class, or buying a self-help 
book.   Generally these individuals are successful in action-oriented programs.  
Individuals with substance use disorders in the preparation stage are seeking help for 
their disorder or making some other plan to address the problem (DiClemente et al., 
1991; Prochaska & Velicer, 1997; Velicer, Prochaska, Fava, Norman, & Redding, 1998).   
Action.  This is the stage where people have made specific and obvious changes, 
relieving the negative outcomes of their disorder.  In this stage, individuals are actively 
using change processes.  Substance users are reducing or eliminating their illicit 
substance use, and therefore likely experiencing positive outcomes in their health, 
personal life, and work (DiClemente et al., 1991; Prochaska & Velicer, 1997; Velicer, 




Maintenance.  This stage occurs after action.  Individuals in this stage are still 
working to maintain their behavior change, but are not having to apply the change 
processes to the same extent as those in the action stage.  These individuals are more 
confident and experience less temptation than those in the action stage (DiClemente et 
al., 1991; Prochaska & Velicer, 1997; Velicer, Prochaska, Fava, Norman, & Redding, 
1998).   
Decisional Balance.  This construct describes how an individual weighs the pros 
and cons of changing their behavior.  In the precontemplation stage of the TTM, the 
decisional balance will be more heavily weighted towards the cons of change, which 
shifts to balance evenly in the contemplation stage, contributing strongly to the 
ambivalence present in that stage.  In later stages, decisional balance is generally 
weighted more strongly towards the pros of change (Velicer, Prochaska, Fava, Norman, 
& Redding, 1998). 
Temptation. According to Prochaska and Velicer (1997) three variables are 
generally involved in the most tempting situations.  These are cravings, positive social 
situations, and emotional distress or negative affect.  Temptation is generally high in the 
beginning of the change process and decreases in later stages of change.  
Confidence.  This construct describes how strongly a person feels that they can 
cope with tempting situations without relapsing.  This construct generally is low in early 
stages of change and increases in later stages.  Confidence has a moderate negative 
correlation with temptation: often as confidence increases, temptation decreases.  




but also highly confident (DiClemente, Carbonari, Montgomery, & Hughes, 1994; 
Prochaska & Velicer, 1997; Velicer, Prochaska, Fava, Norman, & Redding, 1998). 
Processes of change.  When individuals attempt to make a change, they go 
through the experiential and behavioral processes, both overtly and covertly (Velicer, 
Prochaska, Fava, Norman, & Redding, 1998).  These processes of change propel people 
through the stages of change, acting as the force behind behavior change (Velasquez, 
Crouch, Stephens, & DiClemente, 2016). Most people who make behavior changes use 
multiple change processes, whether they are making that change while in treatment or on 
their own (Velasquez, Crouch, Stephens, & DiClemente, 2016).  Stotts, DiClemente, 
Carbonari, and Mullen (1996) found that in order to make a long-term change, one must 
engage in these processes.  The processes of change are divided into two groups: 
experiential and behavioral.  The experiential processes of change are the cognitions and 
emotions that people engage in to make a change and the behavioral processes of change 
are the behaviors, or actions, that contribute to making a change (Velicer, Prochaska, 
Fava, Norman, & Redding, 1998).  Experiential processes are generally used in early 
stages of change, while behavioral processes are usually used in later stages (Velicer, 
Prochaska, Fava, Norman, & Redding, 1998). A complete description of the experiential 
and behavioral processes can be found in Table 1.   
The experiential and behavioral processes each have unique contributions to the 
change process.  A large contribution of the experiential processes is one’s cognitive and 
affective awareness and interpretation of aspects of change.  For example, consciousness 
raising, which occurs in the earlier stages of change, is the process of becoming aware of 




environmental reevaluation, which both have strong cognitive and affective components, 
involve assessments of one’s self-perspective and environment, and the impact that the 
unhealthy behavior has on those domains (Prochaska, Redding, & Evers, 2013). Social 
liberation is similar to consciousness raising in that it involves increased awareness of the 
impact of the unhealthy behavior, specifically how reducing the unhealthy behavior 
relates to greater social opportunities (e.g., not having to leave a restaurant table to go 
outside and smoke in a nonsmoking restaurant).  It is interesting to note that social 
liberation is an experiential process, but it is also strongly relevant in later stages of 
change.  In the action and maintenance stages, for example, people often change their 
environment in order to support their new healthier behavior (Velasquez, Crouch, 
Stephens, & DiClemente, 2016).   
Three of the behavioral processes, stimulus control, counter conditioning, and 
reinforcement management, are strongly intertwined.  These processes are based on 
behavioral theories developed by Pavlov and Skinner (Velasquez, Crouch, Stephens, & 
DiClemente, 2016). Stimulus control and counter conditioning are based on Pavlov’s idea 
of classical conditioning, where two previously unrelated stimuli are repeatedly paired 
and so one becomes a trigger for the other.  Pavlov’s famous example is of food and a 
bell being paired so that dogs began salivating at the sound of a bell, a previously 
unrelated stimulus.  Using this concept, those in the later stages of change are attempting 
to countercondition themselves from these connected stimuli.  For example, they may 
change their social environment, since they are often tempted to engage in the behavior 
they are trying to change when with particular individuals.  Skinner’s concept of operant 




whether that behavior is repeated, is the basis for the process of reinforcement 
management.  In this process, reinforcers are modified to encourage behavior change, 
reducing the previous positive reinforcers of the harmful behavior and creating new 
rewards for maintaining the healthy behavior.  These three processes especially work to 
modify the triggers and rewards of unhealthy behavior, making the individual more 
resilient in the face of those triggers and rewards (Velasquez, Crouch, Stephens, & 
DiClemente, 2016). 
Depression, Behavior Change, and the TTM Variables 
The research on understanding the influence of depression on the reduction of 
substance use and other wellness outcomes through the TTM variables is not yet fully 
understood (Blume, Schmaling, & Marlat, 2001).  As many symptoms of depression 
influence behavioral change, adults with depression appear to engage in TTM variables 
differently than people who are not depressed.  These symptoms include anhedonia (the 
inability to experience pleasure, which can influence motivation and behavioral 
activation), hopelessness (a belief that nothing will get better), cognitive distortions 
(irrational thoughts and beliefs often used to reinforce negative affect states, which can 
contribute to an irrational understanding of whether behavior change is needed), and 
rumination (repetitive thinking of factors contributing to one’s negative emotional 
experience, usually cognitive distortions, which can also contribute to thoughts of 
behavior change as unnecessary) (Beck, Rush, Shaw, and Emery, 1979).  Depression is 
also related to impairments in the processes of self-regulation, which can reduce one’s 
ability to resist temptation (Lovejoy & Heckman, 2014; Velasquez, Carbonari, & 




change include self-efficacy, which is the belief in one’s ability to succeed in specific 
situations (Bandura, 1977) and has been negatively correlated with depression (Kanfer & 
Zeiss, 1983).   Annis and Davis (1988) found that self-efficacy predicts drinking behavior 
over time. 
Multiple studies show that higher levels of depression are associated with greater 
readiness to change (Blume, Schmaling, & Marlat, 2001; Smith & Tran, 2007).  This is 
likely explained by the TTM model’s explanation that motivation increases when the pros 
of change outweigh the cons (Prochaska & DiClemente, 1982).  Psychiatric severity, 
including depression, has been associated with increased pros of change (Velasquez, 
Carbonari, & DiClemente, 1999).  The negative symptomology of depression may 
strengthen the pros of change, as dually diagnosed individuals struggle more in their 
wellness than individuals with either disorder alone (Blume, Schmaling, & Marlat, 2001; 
Caldwell et al., 2002; Smith & Tran, 2007).  Wells-Parker, Dill, Williams, and Stoduto 
(2006) even found that depression was associated with a greater receptivity to counseling 
and intervention services, indicating a greater readiness to change.  
Even though readiness to change is increased, this does not always result in 
behavioral changes.  Prochaska et al. (2004) found that while depressed smokers 
overwhelmingly were motivated to quit smoking, only one quarter were interested in 
making changes in the following month.  Furthermore, Velasquez, Carbonari, and 
DiClemente (1999) found that psychiatric severity is associated with greater temptation 
as well as more active work to maintain abstinence, possibly explaining why people who 




 Other research shows an increasingly complex relationship between depression, 
reducing substance use, and the TTM variables.  Tsoh and Hall (2004), for example, 
found that depression was not related to the stages of change (although they only 
measured the precontemplation, contemplation, and preparation stages), and that only 
depressive symptoms, but not depression, were related to four TTM constructs: 1) pros of 
decisional balance (these participants valued the pros of smoking more highly and were 
more ambivalent than peers to make a commitment to quit smoking), 2) temptation 
(habitual/addictive and negative affect; these participants had more difficulties in 
resisting smoking in habitual and negative affect situations), and 3) self-reevaluation 
(these participants had a higher level of self-reevaluation, the experiential process of 
change referred to in Figure 1, which is particularly important for moving to the action 
stage of change) (Prochaska, Velicer, Guadagnoli, Rossi, & DiClemente, 1991).  The 
higher endorsement of the pros in decisional balance is in contrast to the previous 
findings of dually diagnosed participants having a higher readiness to change.  Blume, 
Schmaling, and Marlat (2001) found that while higher depression symptomatology was 
correlated with increased efforts to reduce alcohol use at baseline, it did not predict 
changes in drinking over time.    
 Despite the findings indicating a complex, and sometimes contradictory, 
interaction between depression and behavior change as explained by the TTM, they also 
indicate that depression does not prevent individuals from reducing substance use during 
treatment, although it is still higher than nondepressed adults substance use after 
treatment.  However, as data indicate strong negative long-term wellness outcomes for 




needed.  It is possible that aspects of depression encourage behavior change (such as a 
higher level of readiness to change) while others counteract it (such as lower self-efficacy 
and anhedonia).  As the TTM provides a strong theoretical base for behavior change, 
understanding how these factors contribute to behavior change in a dually diagnosed 
adult within this model is necessary.  This knowledge can be used to tailor interventions, 
focusing specifically on the TTM variables that will best enable the dually diagnosed 
client to reduce substance use, improve depressive symptoms, and therefore have a better 
likelihood of long term wellness. 
  Depression and the Experiential and Behavioral Processes. One possible 
explanation for the complex interaction of depression and behavior change is the way that 
depressed adults go through the experiential and behavioral processes. The experiential 
processes rely heavily on cognitive processes, which might be influenced by cognitive 
distortions and rumination.  The behavioral processes, on the other hand, are strongly 
influenced by experiences and behavioral activation, both of which are limited by 
anhedonia.  These depressive symptoms add challenges to the already difficult process of 
reducing substance use.  Perhaps depressed adults experience experiential and behavioral 
processes differently than adults who are not depressed, therefore influencing or 
explaining the complex interaction of these comorbid disorders.  It is even possible that 
depressed adults experience the processes less than those who are not depressed.  As it is 
necessary to go through the processes to ensure long-term behavior change (Stotts, 
DiClemente, Carbonari, & Mullen, 1996), no studies have yet examined each of the ten 
experiential and behavioral processes individually to investigate the influence of 




factors, looking at the individual relationships may contribute a more nuanced 
understanding of behavior change while depressed. 
Depression and Other TTM Variables. Other TTM variables are likely 
involved in creating this complex interaction as well.  As discussed above, readiness to 
change, pros and cons, and temptation have been shown to be experienced differently in 
depressed adults compared to nondepressed adults. There is no support, as of yet, for a 
difference in the stages of change between these two groups.  However, the studies 
conducted thus far (Prochaska et al., 2004; Tsoh & Hall, 2004) are limited in their ability 
to uncover this connection; these studies looked only at the pre-action stages, limiting 
their range and their ability to find a relationship.  This is especially relevant considering 
that the interaction described above (that of having a high readiness to change, but not 
having a plan to change in the immediate future) would be directly related to the stages of 
change, placing many of these individuals in the contemplation stage.  In the 
contemplation stage, ambivalence is high and the pros and cons of making a behavior 
change are generally equal.  It is possible for individuals to remain in this stage, 
sometimes for many years, ruminating about making a behavior change, but maintaining 
their problematic behavior at great cost to themselves and society at large (Prochaska & 
Velicer, 1997; Velicer, Prochaska, Fava, Norman, & Redding, 1998).   It is possible that 
depression may play a role in maintaining this ambivalence, as people who are depressed 
experience decreased confidence, increased pessimism, and difficulty making decisions, 
all of which could contribute to an individual’s ambivalence.  As ongoing research 
continues to uncover the nuances of the TTM, it would be helpful to gain an increased 




stage of change, specifically on the contemplation stage.  Therefore, an investigation into 
the relationship between comorbidity and stages of change, using a scale that measures 
all stages of change, would add further understanding to this area of research.   
Statement of the Problem 
Several studies have established that illicit drug use is associated with great 
wellness and economic cost, on par with other major health problems, requiring focused 
intervention to address and ameliorate it (Office of National Drug Control Policy, 2011; 
Office of National Drug Control Policy, 2014).  One challenge facing substance use 
intervention is comorbid depression.  People with substance use disorders often have 
depression, which is implicated in worse mental and physical health outcomes (Mills et 
al., 2009; Pettinati, O’Brien, & Dundon, 2013).  Studies show that while intervention is 
effective in reducing substance use for those with and without depression, dually 
diagnosed adults begin treatment with a higher rate of substance use.  As a result, dually 
diagnosed adults continue to use substances at a higher rate after intervention and 
continue to use substances at a higher rate after intervention (Mills et al., 2009; Pettinati, 
O’Brien, & Dundon, 2013).  A better understanding of how to treat dually diagnosed 
adults is imperative to improve treatment outcomes for this group. 
The TTM is a well-known framework for understanding substance use behavior 
and response to substance use interventions (Prochaska & DiClemente, 1984). However, 
how depression impacts the change process is not yet fully understood within the TTM 
framework.  Multiple studies have indicated that people who are depressed report 
different levels of the various TTM variables, compared to people who are not depressed.  




readiness to change than those who are not depressed (Blume, Schmaling, & Marlat, 
2001; Smith & Tran, 2007).  In adults who are not depressed, this is associated with 
moving through the stages of change more quickly; however, adults who are depressed 
do not change any more quickly than those who are not depressed (Prochaska et al., 
2004).   
The purpose of this study was to investigate whether adult substance users with 
elevated depressive symptoms seeking to change their substance use are different 
compared with nondepressed substance users on the TTM variables, such as processes of 
change, stages of change, readiness to change, decisional balance, temptation, 
confidence, and pros and cons.  This study also examined how successful adults with 
elevated depressive symptoms, compared to the nondepressed adults, are at reducing their 
substance use.  Furthermore, this study investigated if adults with elevated depressive 
symptoms who are more successful at reducing their substance use are different on the 
TTM variables compared to adults with elevated depressive symptoms who are not 
successful, as well as what type of intervention adults with elevated depressive symptoms 
best respond to. 
These research questions were investigated using extant data from a feasibility 
study funded by the National Institute on Drug Abuse (NIDA) completed in 2006 by Dr. 
Mary Velasquez and colleagues on a TTM intervention for substance use.  Participants 
(N=138) who met the DSM-IV criteria for cocaine use or dependence disorder were 
recruited from the Substance Abuse Research Center in the University of Texas Mental 
Sciences Institute in Houston, Texas. Participants were placed into groups that were 




modified for cocaine users (n=82, six groups total), or 2) an education and advice group 
(n=56, four groups total). Data on substance use, TTM constructs, behavioral health 
symptoms, and other factors were collected at the beginning of the intervention, the end 







 This study was performed using extant data collected in 2006 to assess the 
feasibility and efficacy of a transtheoretical model (TTM) group treatment substance 
abuse intervention compared to a traditional education and advice substance abuse 
intervention (Velasquez, Stotts, von Sternberg, Dodrill, & Carbonari, 2009).  
Participants 
The parent study included 138 participants. Participants were an average of 40.6 
years old. Twenty-four percent of the sample were women and 75.6% were men.  The 
sample was 72.2% Black, 19.4% White, and 8.3% Latino (see Table 2).  There were no 
statistically significant differences between groups on sociodemographic characteristics.  
Eligible participants were over 18 years old and met the criteria for cocaine-use or 
dependence.  The participants had used cocaine for an average of 14.2 years (see Table 
3). Eighty-two of the participants were in the TTM condition (six treatment groups total) 
and 56 were in the Education-Advice condition (four treatment groups total).  Forty-two 
participants endorsed clinically significant depression symptoms (a t-score of 62 or 
higher) at both intake and post-treatment timepoints.  For further sociodemographic, 
drug, and treatment information see Table 3. 
Instrumentation 
Brief Symptom Inventory. The Brief Symptom Inventory (BSI; Derogatis, 1993; 
see Appendix B) is a 53-item self-report measure that uses a 5-point Likert scale to assess 
psychiatric severity on several domains.  This measure is a short form of the Symptom 




Symptoms Index (GSI) as well as nine subscales, including one for depressive symptoms. 
The reliability of this measure has been established by many studies, with the reliability 
of the subscales averaging .7 (Derogatis, 1993).  Due to its good psychometric properties 
and relatively brief administration time, this measure has been used extensively in 
research studies on addiction, including cocaine, methamphetamines, and ecstasy, as well 
as for other populations such as residential therapeutic communities, pharmacological 
studies, and therapy for couples in substance abuse treatment (Wang et al., 2010).  
Because this study is interested in the change process of adults with elevated depressive 
symptoms before and after treatment, participants who are above the clinical cutoff score 
of the BSI at both intake and post-intervention (rather than at only one time point) will be 
examined as having elevated depressive symptoms (Derogatis, 1993). 
Processes of Change Questionnaire.  The Processes of Change Questionnaire 
(PCQ; Prochaska, Velicer, DiClemente, & Fava, 1988; see Appendix C) is a self-report 
scale that was adapted for this study for cocaine.  The PCQ measures the ten experiential 
and behavioral processes of change on a Likert scale from 1 (never) to 5 (repeatedly).  
Many studies have established the PCQ’s reliability and validity for various behaviors, 
including multidrug use (Belding, Iguchi, Lamb, & Lakin, 1995).  For example, in a 
sample of cocaine-dependent patients in an outpatient program, the Chronbach Alphas for 
the experiential subscale was .82 and behavioral subscale was .84 (Stotts, Schmitz, 
Rhoades, & Grabowski, 2001).  The PCQ is used extensively in addiction research and 
has been adapted for use in weight management interventions (Andrés, Saldaña & 




translated and validated for use in other languages (Eeckhout, Francaux, & Philippot, 
2012). 
Abstinence Self-Efficacy Scale. (ASE; see Appendix D) The Abstinence Self-
Efficacy Scale, adapted for this study for cocaine, is a 27-item self-rated scale.  This scale 
measures participants’ efficacy to refrain from cocaine use in commonly tempting 
situations by assessing their confidence to abstain from 1 (not at all confident) to 5 
(extremely confident) in each of the various situations.  This scale was modified to also 
assess temptation under the same high-risk situations.  Rosenbloom (1991) found that this 
scale has a high reliability when applied to cocaine, with Chronbach Alphas of the 
subscale scores ranging from .82 to .88.  Many research studies on addiction utilize this 
measure, and it has been assessed for use with specific groups (Kim, Kim, & Gulick, 
2009) as well as translated for use internationally, including in Ghana (Glozah, Adu, & 
Komesuor, 2015), Germany (Zingg et al., 2009), and Korea (Yang et al., 2017). 
Decisional Balance Scale.  (See Appendix E) The Decisional Balance Scale 
measures participants’ pros and cons of using cocaine.  This measure has two subscales 
yielding separate scores for the pros of making a behavior change and the cons of making 
that behavior change.  The responses to items in each subscale are added together and 
divided by six (the number of items in each subscale) to get an average score of both the 
pros and the cons of the behavior change.  This 12-item measure has a high level of 
internal consistency when applied to cocaine; based on the findings of Prochaska, et al., 
(1994), the Chronbach Alpha of the Pros subscale is .86 and of the Cons subscale is .87.  
This scale has been adapted for multiple uses including with adolescent populations 




Percy, Brown, & Yang, 2006), and when translated to Turkish (Bektas, Ozturk, & 
Armstrong, 2010). 
University of Rhode Island Change Assessment Scale. The University of 
Rhode Island Change Assessment Scale (URICA; McConnaughy, Prochaska, & Velicer, 
1983; see Appendix F) is a 28-item questionnaire widely used in addiction literature 
(Tambling & Ketring, 2014) and modified for cocaine in this study.  It is a self-report 
measure, which operationally defines four of the TTM stages: precontemplation, 
contemplation, action, and maintenance.  The scale has established reliability in multiple 
samples [in a sample from DiClemente and Hughes (1990), the Chronbach Alphas ranged 
from .69 to .82 and in the Project MATCH sample (Carbonari & DiClemente, 2000) the 
Chronbach Alphas ranged from .68 to .85] and among a wide array of studies assessing 
addiction and substance use disorders (Field, Adinoff, Harris, Ball, & Carroll, 2009).  
Timeline Follow-Back. The Timeline Follow-Back (TLFB; Sobell & Sobell, 
1996, 1980; see Appendix G) is a structured interview that assesses past drug and alcohol 
use for each day of the assessment period.  This interview uses a calendar to facilitate 
enhanced recall of past drug use behavior and has established reliability and validity in 
alcohol and drug-using populations (Fals-Stewart et al., 2000; Sobell & Sobell, 1980). 
This measure has been used and evaluated extensively since its development in the 1970s 
and has been shown to have excellent psychometric properties in diverse settings (Sobell, 
Brown, Leo, & Sobell, 1996).   Percent days use (PDU) for alcohol and cocaine was 







Recruitment of participants.  Participants were recruited at a university-based 
outpatient substance use disorders clinic. Recruitment was done through newspaper ads, 
radio ads, flyers, brochures, and letters sent to mental health professionals indicating that 
treatment was available.  An intake assessment was completed when participants were 
recruited.  This included providing information on the study and gathering demographic 
information, personal history, and degree of cocaine and other substance use.  
Participants were then assigned to the next available group, which was randomized into 
either the TTM or the Education-Advice conditions.  On average, the group began 
thirteen days after participant intake. 
 Intervention and data collection.  Groups in each of the conditions met two times 
per week for six weeks for a total of twelve 90-minute sessions.  Participants were 
assessed on all measures at intake, post-treatment (three months post-intake), and follow-
up (three months post-intervention). Two experienced masters or doctoral level therapists 
led each group and remained with the group for all twelve sessions of treatment. For both 
conditions, the therapists were highly trained in the respective interventions by the 
research team.  Training for the TTM group leaders included learning about the TTM, 
especially the processes of change (POC), the treatment protocol, and practicing the 
various techniques including role plays.  More emphasis was placed on process, rather 
than education or advice in the TTM group.  Training for the control group leaders 
included emphasizing a didactic style in the group and allowing discussion of the 
treatment materials. Education and advice were emphasized in the control group.  The 




provided weekly supervision for the therapists.  Furthermore, after each session therapists 
and participants completed evaluation forms to evaluate treatment fidelity and therapist 
competence.   
TTM intervention.  The manual for the TTM group was derived from Group 
Treatment for Substance Abuse: A Stages-of-Change Therapy Manual (first edition 
published in 2001; Velasquez, Gaddy Maurer, Crouch, & DiClemente, 2001).  This 
intervention was modified by a group of TTM experts to be a twelve-session group 
therapy intervention for cocaine use focused on the processes of change.  This treatment 
promotes change through focus on the processes of change: the first six sessions focus on 
the experiential processes and following six sessions focus on the behavioral processes.  
The techniques in this intervention are modified from other systems of therapy, 
specifically MI and CBT, but also psychoeducation, values clarification, relapse 
prevention, and social skills training.    
Education-advice intervention. The Education-Advice group manual was based 
on traditional outpatient intervention strategies for building skills to successfully reduce 
cocaine use.  Each session was composed of both a didactic and a discussion component; 
clients were taught the new concepts then discussed how it related to their own cocaine 
use. Session content included an introduction to the biopsychosocial model of addiction 
and symptoms associated with cocaine use, defense mechanisms, social support, effects 
of cocaine on the brain, the disease model, negative consequences, stages of recovery, 
nutrition, codependency, HIV and cocaine abuse, and job finding strategies. 
Findings from the feasibility study. The original study found that participants in 




during treatment and 23% three months post-treatment (Velasquez, Stotts, von Sternberg, 
Dodrill, & Sampson, 2009).  While overall there was no difference between treatment 
groups, the study did find that depending on the participant’s stage of change, they 
reduced their cocaine use more in the treatment group than in the control group.  That is, 
if they were in an earlier stage of change upon entering into the study (precontemplation 
or contemplation) they reduced their cocaine use more in the TTM group, while if they 
were in a later stage of change they reduced their cocaine use more in the education-
advice intervention group.  The researchers proposed that substance use intervention is 
most effective when targeting processes of change that are congruent with the readiness 
to change of the individual.  That is, if the participant has little motivation to change and 
is in the precontemplation stage at baseline then there would likely be a great benefit 
from an intervention that strongly addresses the processes of change.  However, if the 
participant is motivated and in the action stages of change, then advice and 
psychoeducation on how to make the change would likely be more beneficial and 
produce a greater amount of change. 
Analyses 
 Preliminary Analyses. Descriptive statistics (means, ranges, standard deviations, 
minimum and maximum values) were calculated for each of the criterion variables.  The 
independence assumption was violated in this study as participants were in groups 
together over time and therefore influenced one anther, resulting in shared variance in 
their outcomes.  To ensure that no other assumptions were violated, the data was assessed 




Research Question 1: How do adults with and without elevated depressive 
symptoms differ on TTM variables? 
Hypothesis 1a: Adults with elevated depressive symptoms have statistically 
significantly different profiles for the processes of change compared to adults who are not 
depressed. 
Rationale: Symptoms of depression such as cognitive distortions and anhedonia 
make it difficult for adults with elevated depressive symptoms to navigate the 
experiential (which has strong cognitive and affective components, both associated with 
depression) and behavioral processes (which could be hindered by anhedonia and 
hopelessness).  
 Analysis: The subscale scores (converted to t-scores) on the PCQ of adults with 
elevated depressive symptoms were compared to the subscale scores on the PCQ of 
nondepressed adults through three separate profile analyses at the three time points 
(intake, post-treatment, and follow-up).  Profile analysis is a special case of multivariate 
analysis of variance (MANOVA) used when there are multiple dependent variables all 
measured on the same scale (Tabachnick & Fidell, 2013).  This method is typically used 
to determine whether groups have similar profiles on a set of measures, such as the 
subscales of the PCQ.  Profile analysis is robust to the violation of the independence 
assumption, which occurs in group interventions such as in this study. See Figure 2 for an 
example of profile analysis from Carbonari and DiClemente (2000).  Three types of 
hypotheses are examined in profile analysis: parallelism, overall difference, and flatness 
(Tabachnick & Fidell, 2013). Parallelism tests whether the different groups have parallel 




considered a test of interaction.  Overall difference, or the levels hypothesis, is the 
question regarding whether the groups, regardless of parallel profiles, have different 
average scores on the collected measures (Carbonari & DiClemente, 2000; Tabachnick & 
Fidell, 2013).  The final question, flatness, concerns whether the dependent variables all 
elicit the same or similar responses, independent of the groups.  Parameter estimates were 
used to determine if the groups had significantly different scores on the individual 
variables. 
Hypothesis 1b: Adults with elevated depressive symptoms endorse higher 
contemplation stage ratings at post-treatment and follow-up compared to those who are 
not depressed. 
Rationale: Adults with elevated depressive symptoms have fewer emotional 
resources and so struggle with initiating change. 
Analysis: Repeated-measures ANOVA was used to compare the mean score of 
adults with elevated depressive symptoms on the Contemplation subscale of the URICA 
to that of nondepressed adults at intake, post-intervention, and follow-up time points. 
Repeated-measures ANOVA, also referred to as within-subjects ANOVA, is used to 
compare groups consisting of the same participants on a dependent variable across 
multiple time-points.  The error term in repeated-measures ANOVA factors in the 
variability of the individual participants, as well as the variability between groups, to 
account for the individual differences in the participants (Tabachnick & Fidell, 2013).  
Hypothesis 1c:  Adults with elevated depressive symptoms are statistically 
significantly higher on temptation, pros of change, and contemplation; lower on 




Rationale: Adults with elevated depressive symptoms are less likely to have the 
emotional resources to resist temptation and have worse symptomology than non-dually 
diagnosed adults making them more interested in changing.  They also tend to have lower 
self-efficacy, which is associated with confidence. 
Analysis: Using profile analysis, as described in the analysis of Hypothesis 1a, the 
mean scores of adults with elevated depressive symptoms, converted to T-scores, from 
the ASE, the ASE modified for temptation, the subscales of the URICA, and the 
subscales of the Decisional Balance Scale were compared to those nondepressed 
individuals.  A profile analysis was performed at each time-point (intake, post-
intervention, and follow-up).   
Research Question 2: Do people with elevated depressive symptoms reduce 
their substance use as much as people who are not depressed? 
Hypothesis: There is no statistically significant difference in substance use 
reduction between adults with elevated depressive symptoms compared to adults who are 
not depressed. 
Rationale: Findings from previous studies (Blume, Schmaling, & Marlat, 2001; 
Mills et al., 2009) indicate that depressed adults and nondepressed adults reduce 
substance use the same amount after treatment.  
Repeated Measures ANOVA, as described in the analysis of Hypothesis 1b, was 
used to compare the percent days use of cocaine (PDU; as informed by the TLFB) of 
people with elevated depressive symptoms and people who are not depressed at three 




Research Question 3: What is the TTM variable profile of adults with 
elevated depressive symptoms who are more successful at reducing cocaine use 
compared to those who are less successful at reducing cocaine use at follow up? 
Hypothesis: More successful adults with elevated depressive symptoms are 
statistically significantly lower on temptation and higher on confidence and the processes 
of change compared to those who are less successful. 
Rationale: Those adults with elevated depressive symptoms who have higher 
confidence, lower temptation, and more processes of change use are more able to enact 
and maintain behavior change. 
Adults with elevated depressive symptoms who at the follow-up time point 
abstained from cocaine use, used moderately (less than ten PDU), and used heavily (more 
than ten PDU) were compared to each other.  The groups were compared using profile 
analysis, as described in the analysis of Hypothesis 1a, on the mean scores of the TTM 
variables (temptation, confidence, pros and cons, stages, and processes of change) 
converted to T-scores. 
Research Question 4: Which treatment condition is more effective in 
reducing cocaine use in adults with elevated depressive symptoms? 
Hypothesis: Adults with elevated depressive symptoms have a statistically 
significant greater reduction in cocaine use in the TTM group, compared with adults with 
elevated depressive symptoms in the Education-Advice group.   
Rationale: The TTM group provides more focus on the processes of change, 
providing adults with elevated depressive symptoms more opportunity to engage with 




Repeated Measures ANOVA, as described in the analysis of Hypothesis 1b, was 
used to compare the PDU of cocaine of depressed adults in the TTM group to depressed 







 Preparation of the data, calculation of descriptive statistics, checking assumptions, 
profile analyses, and general linear model (GLM) analysis of variance (ANOVA) were 
conducted using SPSS 23. 
Preliminary Analyses 
Descriptive statistics (means, ranges, standard deviations, minimum, and 
maximum values) were calculated for each of the criterion variables (see Tables 5 
through 8). As participants were in groups together over time and therefore influenced 
one another, resulting in shared variance in their outcomes, the independence assumption 
was violated in this study.  To ensure that no other assumptions were violated, the data 
were assessed for approximate normality of distribution, outliers, and sphericity.  
Inspection of frequency distributions, histograms, and box plots yielded no outliers. 
Sphericity was assessed with each univariate ANOVA analysis.  The normal distribution 
of continuous variables was determined by: (a) the normal curves for each variable 
observed in the histograms, (b) the skew values for each variable, and (c) the kurtosis 
values for each variable (Kim, 2013).  No violations of normality were found. Finally, 
intraclass correlations (ICC) were performed to detect any variation between the 
intervention groups, as the treatment was delivered through group interventions.  The 
ICCs indicated high reliability between the groups. The average measure ICC of all of the 
transtheoretical model (TTM) variables, including the experiential and behavioral 
processes of change, was .897 with a 95% confidence interval from .775 to .970 




of change was .891 (9,36)=.891 with a 95% confidence interval from .727 to .969 
[F(9,36)=9.138, p<.001) and for the behavioral processes of change it was .960 with a 
95% confidence interval from .903 to .989 [F(9,45)=24.983, p<.001).  In sum, all 
statistical assumptions required for repeated measures ANOVA and profile analysis were 
met. 
Primary Analyses: Tests of Research Questions 
 This quantitative experimental study examined the differences in multiple TTM 
variables between participants with elevated depressive symptoms and nondepressed 
participants in an intervention to reduce cocaine use. The results of the following research 
questions are presented below. For all comparisons, significance was achieved if the F 
ratio met or exceeded the .05 level. 
Research Question 1. How do adults with elevated depressive symptoms 
differ on TTM variables compared to nondepressed adults? 
Hypothesis 1a: Adults with elevated depressive symptoms have statistically 
significantly different profiles for the processes of change compared to adults who are not 
depressed. 
 Results: A profile analysis was performed on the 11 processes of change (POC 
subscales) of the Processes of Change Questionnaire (PCQ; social liberation was divided 
into experiential and behavioral subscales).  The grouping variable was elevated 
depressive symptoms, operationalized by whether the participants were above the cutoff 
for the depression subscale of the Brief Symptom Inventory (BSI) at the beginning and at 
the end of treatment. This analysis was done at three time points: pre-treatment, post-




Lambda, the profiles did not significantly deviate from parallelism, F(10,99)=1.506, 
p=.148, that is, the profile of the two groups did not significantly deviate from one 
another.  Post-treatment profiles (see Figure 4) and treatment profiles at the three-month 
follow-up time point (see Figure 5) did significantly deviate from parallelism, F(10, 
90)=2.340, p=.017, η2=.206 and F(10, 88)=2.027, p=.040, η2=.187 respectively.  This 
indicates that participants with elevated depressive symptoms and those without elevated 
depressive symptoms used the processes of change differently at the end of treatment and 
again three months later.  
The other hypotheses tested in profile analysis, the levels and flatness hypotheses, 
were not significant at all three time points.  The flatness hypothesis tests whether the 
dependent variables all elicit the same or similar responses, independent of the groups.  
For this test sphericity was violated at all three time points so the Greenhouse-Geisser 
correction was used [pre-treatment F(1, 8.213)=0.239, p=.985, post-treatment F(1, 
6.937)=0.104, p=.998, and three-month follow-up F(1, 6.183)=.258, p=.959].  The levels 
hypothesis tests whether the groups on average have different scores (i.e. a univariate 
analyses testing the difference in the Grand Means) on the collected measures.  These 
findings were not significant [pre-treatment F(1, 108)=0.50, p=.823, post-treatment F(1, 
99)=.024, p=.876, and three-month follow-up F(1, 97)=1.670, p=.199]. 
To investigate differences in the individual variables at each time point parameter 
estimates were used.  These indicated that at intake the individual processes of change 
reinforcement management, t(109)=1.983, p=.05, η2=.035, and helping relationships, 
t(109)=2.193, p=.035, η2=.041, were significantly different between participants with and 




Parameter estimates at post-treatment indicated that reinforcement management, a 
behavioral process of change, was significantly different between participants with and 
without elevated depressive symptoms, t(100)=2.448, p=.016, η2=.057. Finally, 
parameter estimates indicated that at follow-up consciousness raising, t(98)=-2.031, 
p=.045, η2=.041, self reevaluation, t(98)=-2.007, p=.006, η2=.076, and environmental 
reevaluation t(98)=2.004, p=.006, η2=.074, were significantly different between 
participants with and without elevated depressive symptoms.  These are all experiential 
processes of change.  Before and after treatment the differences between participants with 
and without elevated depressive symptoms on individual variables were restricted to 
behavioral processes of change, however at the three-month follow-up, they were 
different on several experiential processes of change.  At follow-up when nondepressed 
participants were utilizing more behavioral processes of change, which are generally 
utilized further along in the stages of change, participants with elevated depressive 
symptoms were still strongly utilizing the experiential processes of change, especially 
consciousness raising, self-reevaluation, and environmental reevaluation.  These findings 
support the hypothesis that adults with elevated depressive symptoms have significantly 
different profiles compared to nondepressed adults on the processes of change. 
Hypothesis 1b: Adults with elevated depressive symptoms endorse higher 
contemplation stage ratings at post-treatment and follow-up compared to those who are 
not depressed. 
Results: A GLM repeated-measures was performed on the contemplation stage 
subscale of the University of Rhode Island Change Assessment Scale (URICA) at intake, 




elevated depressive symptoms, operationalized as described in the results for hypothesis 
1a.  Mauchly’s test of sphericity indicated it was not violated (p=.444).  There was no 
significant interaction effect, F(2,176)=.961, p=.384, no significant effect of time, 
F(2,176)=.210, p=.811, and no main effect, F(1,88)=.130, p=.719.  This indicates that the 
participants with elevated depressive symptoms had similar scores on the contemplation 
subscale compared to the nondepressed participants and there was no difference between 
the groups over time.  These findings do not support the hypothesis, and instead indicate 
that participants with and without elevated depressive symptoms had similar endorsement 
of the contemplation stage over time. 
Hypothesis 1c: Adults with elevated depressive symptoms are statistically 
significantly higher on temptation, pros of change, and contemplation; lower on 
confidence; and similar on the other variables compared to nondepressed adults. 
Results: A profile analysis was performed on the TTM variables (experiential 
processes, behavioral processes, temptation, confidence, pros of change, cons of change, 
precontemplation stage of change, contemplation stage of change, and action stage of 
change) with the grouping variable elevated depressive symptoms. This analysis was 
done at three time points: pre-treatment, post-treatment, and at the three-month follow-
up.  At the first two time points, the profiles (see Figures 6 and 7) did not significantly 
deviate from parallelism [intake F(8,101)=1.493, p=.169; post-treatment F(8,91)=1.680, 
p=.114].  However, at the three-month follow-up (see Figure 8), the profiles did 
significantly deviate from parallelism, F(8, 84)=2.834, p=.008, η2=.213.  Participants 




way at the first two time points, but engaged in the TTM variables differently three 
months after treatment. 
The flatness and levels hypotheses were not significant in this profile analysis.  
For the flatness hypothesis, sphericity was violated at all three time points so the 
Greenhouse-Geisser correction was used [pre-treatment F(1, 5.729)=0.241, p=.959; post-
treatment F(1, 4.902)=.054, p=.998; and three-month follow-up F(1, 4.602)=.095, 
p=.990]. The levels hypothesis was also not significant at each time point [pre-treatment 
F(1,108)=.885, p=.349; post-treatment: F(1,98)=.090, p=.765; and three-month follow-
up: F(1,91)=.313, p=.577]. 
An investigation between the individual TTM variables through parameter 
estimates showed that temptation was significantly higher in participants with and 
without elevated depressive symptoms at the pre-treatment and post-treatment time points 
[intake t(109)=-3.169, p=.002, η2=.085; post-treatment t(99)=-2.456, p=.016, η2=.058].  
At the three-month follow-up, parameter estimates indicated participants with elevated 
depressive symptoms used experiential processes significantly more than nondepressed 
participants, t(92)=-2.273, p=.025, η2=.054.  Participants with elevated depressive 
symptoms endorsed higher levels of temptation for using cocaine compared to 
nondepressed participants at the first two time points, then three months after treatment 
were more engaged with the experiential processes of change.  These findings partially 
support the hypothesis; temptation was higher in participants with elevated depressive 
symptoms at two time points, but pros of change, contemplation, and confidence were 




Research Question 2: Do people with elevated depressive symptoms reduce 
their substance use as much as people who are not depressed? 
Hypothesis: There is no statistically significant difference in substance use 
reduction between adults with elevated depressive symptoms compared to adults who are 
not depressed. 
Results: A GLM repeated measures was performed on the percent days use of 
cocaine score derived from the Timeline Follow-Back (TLFB) at intake, post-treatment, 
and three-month follow-up time points. The grouping variable was elevated depressive 
symptoms, operationalized as described in the results for hypothesis 1a.  Mauchly’s test 
indicated that sphericity was violated (p=.000) so a multivariate analysis of variance 
(MANOVA) was performed.  No significant interaction, F(2,93)=1.678, p=.191, or main 
effect were found, F(1,94)=.184, p=.669, but there was a significant effect of time, 
F(2,93)=18.652, p=.000, η2=.286.  Cocaine use for all participants decreased over the 
course of the study, and there was no difference in reduction between participants with 
and without elevated depressive symptoms, as hypothesized.  
Research Question 3: What is the TTM variable profile of adults with 
elevated depressive symptoms who are more successful at reducing cocaine use 
compared to those who are less successful at reducing cocaine use at follow up? 
Hypothesis: More successful adults with elevated depressive symptoms will be 
statistically significantly lower on temptation and higher on confidence and the processes 
of change compared to those who are less successful. 
Results: A profile analysis was performed on the TTM variables.  The grouping 




cocaine use, operationalized by whether the participants with elevated depressive 
symptoms reported abstaining from cocaine use at follow up, reported a percent day use 
(PDU) of cocaine greater than zero and less than ten percent, or reported a PDU of 
cocaine greater than ten percent.  Profile analysis was done at three time points: pre-
treatment, post-treatment, and at the three-month follow-up.  Of the adults with elevated 
depressive symptoms, eight were successful at eliminating cocaine use (abstaining 
group), 13 reported greater than zero and less than ten percent PDU (moderate use 
group), and 17 reported greater than ten percent PDU (heavy use group). 
At all time points, the profiles did not significantly deviate from parallelism 
[intake F(16,54)=.933, p=.539; post-treatment F(16,54)=.802, p=.677; and at follow up 
F(16,50)=.930, p=.542].  The flatness hypothesis and levels hypothesis were not 
significant at all three time points, as well [flatness: pre-treatment F(8, 27)=.890, p=.538, 
post-treatment F(8, 27)=.802, p=.677, and three-month follow-up F(8,25)=1.684, p=.152; 
levels: pre-treatment F(2,34)=1.091, p=.347; post-treatment: F(2,34)=.799, p=.458; and 
three-month follow-up: F(2.32)=1.006, p=.377].   
There were significant findings when examining each TTM variable individually, 
however, specifically on behavioral processes and temptation.  Pre-treatment 
[t(36)=2.135, p=.040] and follow-up [t(36)=2.118, p=.036] parameter estimates indicated 
that the behavioral processes were significantly different between the abstaining, 
moderately-using, and heavily-using groups.  At follow-up, the abstaining group used the 
behavioral processes the most, while the heavy-use group used them the least.  Follow-up 
parameter estimates also indicated that temptation was lowest among the abstaining 
group and highest among the heavy use group, t(36)=-2.365, p=.024.  While the profiles 
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of the groups were not different, the hypothesis was partially supported in that temptation 
and processes of change were different between the groups. 
Research Question 4: Which treatment condition is more effective in 
reducing cocaine use in adults with elevated depressive symptoms? 
Hypothesis: Adults with elevated depressive symptoms will have a statistically 
significant greater reduction in cocaine use in the TTM group, compared with those in the 
Education-Advice group.   
Results: A GLM repeated-measures was performed on the percent days use 
(PDU) score derived from the TLFB at intake, post-treatment, and three-month follow-up 
time points of the participants with elevated depressive symptoms.  The grouping 
variable was the treatment condition.  Sixteen participants with elevated depressive 
symptoms were in the Education and Advice treatment condition and 22 were in the TTM 
treatment condition.  Mauchly’s test indicated that sphericity was violated (p=.000) so a 
MANOVA was used.  No significant interaction (see Figure 9), F(2,93)=1.687, p=.191, 
or main effect was found, F(1,36)=.260, p=.613, but there was a significant effect of 
time, F(2,93)=18.652, p=.000, η2=.286. This indicates that participants with depressive 
symptoms all reduced their cocaine use over the course of treatment, regardless of their 
treatment condition, which does not support the hypothesis.  
Summary 
The processes of change profiles of participants with and without elevated 
depressive symptoms were significantly different at post-treatment and follow-up time 
points.  Parameter estimates indicated that participants with elevated depressive 
symptoms utilized behavioral processes of change less often than nondepressed 
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participants at intake and post-treatment, especially reinforcement management and 
helping relationships.  At follow-up, the participants with elevated depressive symptoms 
were using the behavioral processes similarly to the nondepressed participants, but were 
using experiential processes much more, especially consciousness raising, self-
reevaluation, and environmental reevaluation. 
On the other TTM variables, participants with and without elevated depressive 
symptoms had significantly different profiles at follow up.  Participants with elevated 
depressive symptoms also had significantly higher scores on temptation at intake and 
post-treatment.  Participants with elevated depressive symptoms also used the 
experiential processes significantly more than nondepressed participants at follow-up.  
There were no other significant differences between participants with and without 
elevated depressive symptoms, including no significant difference on the contemplation 
subscale. 
Overall, cocaine use decreased significantly over the course of the study, and 
there was no significant difference in cocaine reduction for participants with and without 
elevated depressive symptoms.  Furthermore, adults with elevated depressive symptoms 
all reduced their cocaine use over the course of treatment, regardless of their treatment 
condition. The participants with elevated depressive symptoms who were most successful 
in eliminating cocaine use had significantly lower temptation and used the behavioral 
processes of change most at follow-up compared to the moderately-using group and the 
heavily-using group.   
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Discussion 
Cocaine and other illicit drug abuse is a severe health and financial burden on our 
society (Office of National Drug Control Policy, 2011; Office of National Drug Control 
Policy, 2014). Depression frequently co-occurs with substance use disorders.  Current 
drug abuse treatment, while it does reduce substance abuse, still results in a higher rate of 
substance use after intervention in dually diagnosed individuals compared to 
nondepressed adults, as well as worse mental and physical health outcomes for dually 
diagnosed compared to nondepressed adults (Mills et al., 2009; Pettinati, O’Brien, & 
Dundon, 2013).  These outcomes include increased suicidal ideation, poorer social 
functioning, and increased rates of health care utilization (Sullivan, Fiellin, & O'Connor, 
2005). As many symptoms of depression influence behavioral change, adults with these 
symptoms may engage in substance abuse treatment differently than people who are not 
depressed.  An improved understanding of this dually diagnosed population will help 
improve treatments and ameliorate the impact of these comorbid diagnoses.  
The transtheoretical model of change (TTM) framework is frequently used for 
understanding substance use behavior change and response to substance use 
interventions, but there is limited information regarding the effect of depression on these 
processes (Prochaska & DiClemente, 1984). This study investigated how adults with 
elevated depressive symptoms and cocaine addiction navigate changing addiction 
behavior according to TTM constructs, particularly the processes of change.   The other 
TTM constructs included temptation to use, confidence to abstain, pros of change, cons 
of change, the precontemplation stage, the contemplation stage, the action stage, and the 
maintenance stage. It also examined whether they reduce their substance use as much as 
Chapter 5 
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nondepressed substance users, and how adults with elevated depressive symptoms who 
are successful in reducing substance use compare to those who are not successful.  It was 
hypothesized that cocaine users with elevated depressive symptoms would endorse the 
TTM constructs differently than the nondepressed ones, especially the processes of 
change, but would reduce their cocaine use the same amount as the nondepressed users.  
These questions were examined using profile analysis and general linear model (GLM) 
analysis of variance (ANOVA) on extant data from a stage 1 study completed in 2006 by 
Dr. Mary Velasquez and colleagues on a TTM intervention for substance use. Results 
found that participants with elevated depressive symptoms did use the processes of 
change differently compared to the nondepressed participants, while reducing their 
cocaine use the same as the nondepressed participants. 
Participants with and without Elevated Depressive Symptoms Used the Processes of 
Change Differently in Treatment for Stimulant Use Disorder 
Previous studies that have investigated how comorbidity influences alcohol abuse 
treatment have showed that all participants improve in reducing alcohol consumption, 
including those who are dually diagnosed, however those with comorbid depression 
begin treatment with a higher level of alcohol consumption, so still have a have a higher 
level of alcohol consumption after treatment (Mills et al., 2009).  Similarly, this study 
found that both the participants with and without elevated depressive symptoms reduced 
their cocaine use by the end of treatment and maintained that reduced level of use 
through the three-month follow-up.  Furthermore, participants with elevated depressive 
symptoms responded similarly to the TTM intervention and the psychoeducation 
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intervention.  In each treatment, depressive symptoms did not prevent the participants 
from successfully reducing their cocaine use. 
However, engagement with the processes of change was different between the 
participants with and without elevated depressive symptoms in this study, especially after 
treatment.  As the processes of change (see Table 1) are considered the “machine” of 
change in the TTM and must be engaged in to maintain lasting change (Stotts, 
DiClemente, Carbonari, & Mullen, 1996; Velasquez, Crouch, Stephens, & DiClemente, 
2016), this difference might explain the more severe long-term treatment outcomes of 
dually diagnosed compared to nondepressed substance abusers (Sullivan, Fiellin, & 
O'Connor, 2005).   
The use of experiential compared to behavioral processes of change was different 
between participants with and without elevated depressive symptoms.  There are ten 
processes of change, five of which are experiential and five behavioral.  The experiential 
processes of change have cognitive and affective components while the behavioral 
processes of change require behavioral engagement (Velasquez, Crouch, Stephens, & 
DiClemente, 2016; Velicer, Prochaska, Fava, Norman, & Redding, 1998).  As the 
experiential processes of change are more thought driven, they are typically used during 
the early part of behavior change when a person is debating whether to make a change or 
not (Velicer, Prochaska, Fava, Norman, & Redding, 1998; see Figure 1).  The behavioral 
processes, on the other hand, are more active processes, such as changing one’s 
environment or substituting new behaviors for the one they are attempting to change.  
These are typically used during later stages of change when one is preparing for or 
actually making the change (Velicer, Prochaska, Fava, Norman, & Redding, 1998). 
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However, in this study participants with elevated depressive symptoms were still 
engaging in experiential processes of change three months after ending treatment, a time 
point when most participants had successfully reduced or eliminated their cocaine use 
and maintained that change for three months.  This is not typical of the use of the 
processes of change (Velicer, Prochaska, Fava, Norman, & Redding, 1998).  
In contrast, at this same time point participants with elevated depressive 
symptoms who were more successful at reducing their substance use were using the 
behavioral processes more than those who were using cocaine moderately or heavily.  
This is consistent with the pattern of use of the processes of change established in TTM 
literature (Velicer, Prochaska, Fava, Norman, & Redding, 1998).  This indicates that the 
increased engagement with experiential processes late in behavior change has 
implications for unsuccessful behavior change.  As atypical engagement with the 
processes of change is associated with an inability to maintain the new behavior over 
time (Stotts, DiClemente, Carbonari, & Mullen, 1996), this engagement pattern may 
explain the difference in long-term outcomes between depressed and nondepressed 
substance abusers in treatment, as well.   
Furthermore, this atypical pattern is consistent with depressive symptoms such as 
increased rumination, affective responses, and cognitive distortions. There were even 
differences on the individual processes of change between the participants with and 
without elevated depressive symptoms consistent with features of depression.  Before 
treatment, participants with elevated depressive symptoms struggled with rewarding 
themselves for behavior change (reinforcement management) and identifying 
relationships that will be supportive of their behavior change (helping relationships).  
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These behavioral processes of change require social interaction and a positive sense of 
self-worth, both of which are influenced negatively by depressive symptoms.  This lower 
level of engagement is consistent with depression symptoms of anhedonia and 
hopelessness.  Before initiating behavior change (pre-treatment), participants with 
elevated depressive symptoms struggled with engaging in the aspects of the change 
process that require a sense of self-worth and social engagement.  
After treatment, the individual processes of change that the participants with 
elevated depressive symptoms used differently had a self-critical aspect when used after 
making a behavior change.  These were experiential processes of change, which, as 
mentioned above, are typically used in initial stages of change.  The participants with 
elevated depressive symptoms had a higher awareness of a need to change (consciousness 
raising), increased examination of the behavior and its impact on one’s life (self-
reevaluation), and an increased examination of the behavior and its impact on others 
(environmental reevaluation; Prochaska, Redding, & Evers, 2013).  Tsoh and Hall (2004) 
also found that depressed adults attempting to quit smoking used self-reevaluation more 
than nondepressed adults. These tendencies in depressed adults after making a behavior 
change and maintaining that new behavior, are no longer necessary and focuses the 
participant on the past negative behavior rather than on the successful reduction of 
substance use and the work done to change that behavior.  
Temptation Implicated in Unsuccessful Treatment Outcomes in Participants with 
Elevated Depressive Symptoms 
When participants with elevated depressive symptoms were compared to each 
other on the basis of their success in treatment, temptation to use cocaine was much 
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higher in the least successful participants (i.e., those that used the cocaine the most at the 
end of treatment) compared to the most successful participants (i.e., those that abstained 
or used a small amount of cocaine at the end of treatment).  This indicates that higher 
temptation is related to less successful treatment outcomes among participants with 
elevated depressive symptoms.  Moreover, participants with elevated depressive 
symptoms as a whole were more tempted to use cocaine than nondepressed participants 
before and after treatment.  This is consistent with depressive symptoms: emotional 
distress and negative affect are both a result of depression, and depression impairs self-
regulation, all of which is implicated in reduced ability to resist temptation (Lovejoy & 
Heckman, 2014; Velasquez, Carbonari, & DiClemente, 1999).   
These findings are also consistent with past research showing that lower 
temptation is implicated in more successful treatment outcomes among depressed 
substance abusers.  Carbonari and DiClemente (2000) found that those who successfully 
reduced alcohol consumption after treatment had reduced endorsement of temptation in 
their TTM profile, while those who were not successful had higher levels of temptation at 
the end of treatment.  Floyd et al. (2007), who were investigating the efficacy of a 
motivational interviewing intervention on women who were at risk for an alcohol 
exposed pregnancy, found that temptation for alcohol was a strong enough variable to be 
a confounder, so retained it in their final model.  Tsoh and Hall (2004) found that non-
treatment seeking depressed smokers were more tempted than the nondepressed smokers, 
especially in habitual and negative affect situations.  In depressed adults with a substance 
use disorder, lower temptation is consistently implicated in successful reduction of 
substance use after treatment across studies. 
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Treatment Influenced Participants with Elevated Depressive Symptoms’ Use of 
some TTM Constructs 
Not only did participants with elevated depressive symptoms respond to treatment 
differently in their engagement with the processes of change as discussed earlier, but also 
with their engagement of some of the TTM constructs.  These constructs include the 
experiential processes of change, behavioral processes of change, temptation, confidence, 
pros of change, cons of change, the precontemplation stage, the contemplation stage, and 
the action stage.  While the participants with elevated depressive symptoms reduced 
substance use similarly to the nondepressed participants, they exhibited a different pattern 
of engaging with these variables than nondepressed participants, months after treatment.  
However, based on these constructs, there was no difference between how participants 
with elevated depressive symptoms who abstained or used less cocaine responded to 
treatment compared to those who used more cocaine.  Therefore, treatment impacted 
participants with elevated depressive symptoms as a whole differently than nondepressed 
participants, but did not differentially impact the more successful and less successful 
participants with elevated depressive symptoms. 
Pros of Change Similar between Participants with and without Elevated Depressive 
Symptoms 
 Past studies have had discrepant findings regarding the pros of change, that is the 
reasons people have to make a change (Tsoh & Hall, 2004; Velasquez, Carbonari, & 
DiClemente, 1999).  In this study the pros of change were similar between participants 
with and without elevated depressive symptoms, which may be because these individuals 
were all seeking treatment so saw a need for change from the beginning of treatment.  It 
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is also possible that the emotional toll of depression may not have substantially 
influenced the pros for change, as had been suggested earlier in this document.  
Furthermore, this may help explain why depressive symptoms are not an influencing 
factor for those who get “stuck” in the contemplation stage for long periods of time, as 
being in the contemplation stage involves maintaining an equal balance between the pros 
and cons for change (Prochaska & Velicer, 1997; Velicer, Prochaska, Fava, Norman, & 
Redding, 1998). 
Overall, this study found that participants with elevated depressive symptoms 
were as successful as nondepressed participants in reducing their cocaine use after 
treatment, regardless of whether they were in the Education-Advice intervention or the 
TTM intervention.  However, participants with elevated depressive symptoms engaged 
with the TTM variables differently compared to the nondepressed participants.  This was 
especially notable with the processes of change and temptation variables.  The behavioral 
processes of change were underutilized before treatment and the experiential processes of 
change were over-utilized after treatment, when they were no longer necessary to 
maintain abstinence.  Temptation was endorsed in participants with elevated depressive 
symptoms who were less successful in reducing their cocaine use compared to those who 
were successful.  In sum, the participants with elevated depressive symptoms endorsed 
TTM variables differently than the nondepressed participants, despite reducing their 
cocaine use as much as the nondepressed participants. 
Limitations 
 A significant limitation of this study is in the generalizability of the sample.  The 
demographics of this sample are not consistent with demographics of cocaine users 
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across the United States and therefore the results must be interpreted with caution.  
Specifically, there is a high proportion of male participants, black participants, and 
homeless participants in this sample.  These findings may not apply to all people with a 
stimulant use disorder in the United States and especially may not be generalizable to 
high socio-economic status groups and cocaine users who seek residential treatment. 
This study is also reliant on self-report measures, which have inherent bias.  Self-
report measures require introspective ability, which not all people have.  Despite a desire 
to respond honestly, some may lack the awareness to be able to accurately respond.  
However, self-report measures also rely on the honesty of the participant. Social 
desirability bias drives responders to ascribe more positive traits to themselves and to 
generally reply in a way that makes them appear more favorable (Nederhof, 1985).  
Topics such as substance use and depression are particularly susceptible to social 
desirability bias (Furnham, 1986). Similarly, the designation of depression in this study 
was based on self-report measures, rather than a diagnostic interview.  A diagnostic 
interview would provide a depression diagnosis, rather than an endorsement of depressive 
symptoms.  Despite these drawbacks, self-report measures are a cost-effective way to 
gather large amounts of information from participants, as required in this study.  A 
strength of this study, however, is that it took these biases into account and did a 
biochemical validation of cocaine use, which was found to be congruent with the self-
reported cocaine use. 
A further limitation to this study is the violation of the independence assumption 
inherent in group interventions (McCarthy, Whittaker, Boyle & Eyal, 2017).  Participants 
in this study all received treatment in a group setting over the period of six weeks, which 
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resulted in unavoidable influence of group members on each other.  While profile 
analysis and general linear model analysis of variance tests are robust to violations of 
assumptions, the participants nevertheless have shared variance due to their influence on 
each other in treatment groups over time. 
As anxiety is highly associated with depressive symptoms, it may be a 
confounding variable in this study (Brown, Campbell, Lehman, Grisham, & Mancill, 
2001).  It is possible that anxiety accounts for some of the findings, rather than depressive 
symptoms.  Furthermore, including anxiety in the analysis may make relationships with 
other variables apparent. 
A strength of this study is that it includes follow-up data from three months after 
treatment.  However, for dually diagnosed populations even more long-term data is 
valuable as dually diagnosed populations have negative long-term outcomes such as 
higher rates of substance use and mental health outcomes.  More extended follow-up data 
could also evaluate for outcome differences over time by treatment group between the 
depressed and nondepressed participants.   
Implications for Research 
Despite noted limitations, this study was the first to examine individually the ten 
experiential and behavioral processes associated with the transtheoretical stages of 
change model to investigate the influence of depressive symptoms on treatment and 
behavior change.  As each of the processes engages different components associated with 
depression, this investigation of the individual processes provided a more nuanced 
understanding of behavior change among cocaine users with elevated depressive 
symptoms.  The finding that participants with elevated depressive symptoms engaged in 
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extended use of the experiential processes of change is especially compelling, and merits 
further study.  This finding may have implications in various aspects of substance abuse 
treatment and wellness outcomes.  Future studies should investigate if the extended use of 
experiential processes of change has any impact on reducing substance use, maintaining 
abstinence, quality of life, or depression symptoms.  If the extended use of experiential 
processes of change in participants with elevated depressive symptoms is implicated in 
negative outcomes, then further research to examine how to reduce them following 
treatment is needed.  It is possible that they would diminish after treating the depressive 
symptoms. 
Future research should also consider whether temptation is an important treatment 
target for nondepressed substance abusers.  In this study, temptation endorsement was 
low among the nondepressed participants.  This indicates that it was not an important 
focus for treatment for the nondepressed participants, despite being related to treatment 
success for the participants with elevated depressive symptoms.  It is possible that in past 
studies that found temptation to be a factor in treatment success, temptation mostly 
impacted the members of the sample with elevated depressive symptoms, rather than the 
sample as a whole.  Future studies should take depressive symptoms into account, as it is 
possible that temptation would not be as relevant for the nondepressed adults. 
Finally, participants with elevated depressive symptoms reduced substance use 
similarly to the nondepressed participants, but they exhibited a different pattern of 
engaging with the TTM variables than nondepressed participants.  Future research should 
examine whether these profile differences are linked to more severe outcomes for adults 
with elevated depressive symptoms over time, such as increases in relapse or other 
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mental health outcomes.  Overall, further research is needed to understand how adults 
with elevated depressive symptoms respond to substance abuse treatment and an 
increased understanding of their use of the TTM constructs appears to be promising. 
Implications for Clinical Practice  
As long-term outcomes for dually diagnosed adults are more severe than for those 
with substance use disorders only, modifications to treatment for this population would 
be of great benefit.  This study sheds light on treatment for adults with substance use 
disorders and comorbid depression, as they responded to treatment differently on the 
constructs of the TTM compared to nondepressed participants. In early stages of change, 
treatment for dually diagnosed adults must address the underuse of behavioral processes 
of change.  Later in the process of changing the behavior, the overuse of the experiential 
processes of change by depressed individuals must be considered and incorporated into 
treatment.  Another treatment target for the dually diagnosed population implicated in 
this study is temptation, as reduced temptation is associated with improved outcomes in 
substance use in multiple studies, including this one.   
These treatment targets can all be addressed in a group treatment setting, as well.  
Within group treatment, furthermore, consideration should be given to how groups are 
created.  As dually diagnosed adults utilize the processes of change differently, creating 
groups for these individuals to target this atypical use would improve treatment outcomes 
(Velasquez, Gaddy Maurer, Crouch, & DiClemente, 2001).  Group leaders should also be 
informed on the importance of targeting processes of change use and temptation in group 
members with depressive symptoms. Addressing these critical TTM constructs would 
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likely improve outcomes for dually diagnosed adults in group or individual treatment for 
substance abuse. 
Conclusion 
As dually diagnosed adults have worse health and use outcomes after substance 
abuse treatment, this study examined TTM constructs, looking to better understand this 
relationship.  Using extant data from a feasibility study completed in 2006 by Dr. Mary 
Velasquez and colleagues on a TTM intervention for substance use, this study looked at 
the differences between adults with and without elevated depressive symptoms in 
treatment for cocaine abuse on the TTM constructs (i.e., temptation, confidence, pros of 
change, cons of change, the precontemplation stage of change, the contemplation stage of 
change, the action stage of change, the experiential processes of change, the behavioral 
processes of change, and each individual process of change).   
This study found that dually diagnosed adults do engage with the TTM 
differently, especially with temptation and the processes of change. Individuals with 
elevated depressive symptoms experienced higher levels of experiential processes of 
change after treatment and higher levels of temptation throughout treatment.  These 
findings were related to less successful treatment outcomes and may partly explain the 
difference in long-term outcomes between depressed and nondepressed substance abusers 
in treatment.  
Future research in this area would allow for an increased understanding of the 
nuances of dually diagnosed individuals in treatment for substance abuse. One avenue of 
investigation is the impact that continued engagement with the experiential processes of 
change has on adults with elevated depressive symptoms in substance use change and 
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other mental health outcomes; if participants were followed for a longer period of time 
they might experience worse substance use or health outcomes.  Another area of future 
research is to examine if the endorsement of TTM constructs changes when the 
depressive symptoms are treated.  Examining behavior change in dually diagnosed adults 
through the TTM constructs has proven to be effective. 
Clinical implications of these findings have the potential to reduce the more 
severe long-term outcomes experienced by dually diagnosed individuals.  This study 
found that treatment for dually diagnosed adults must address the underuse of behavioral 
processes of change early in treatment, but in later treatment must address the overuse of 
the experiential processes of change.  Additionally, temptation must be addressed 
throughout treatment as higher temptation has robust implications for worse outcomes.
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Table 1 
The Experiential and Behavioral Processes of Change 
Experiential Processes (generally used in early stages of change) 
Consciousness Raising Increasing awareness of the need to change 
and how to change 
Self-Reevaluation Reexamination of the behavior and how it 
affects his or her life 
Social Liberation Noticing how changes in society and 
environment make it easier to change the 
behavior; noting how the behavior is 
viewed by general society and how society 
encourages healthier options 
Environmental Reevaluation Reappraisal of the impact of the behavior 
on the environment or others  
Dramatic Relief The strong reaction of individuals who 
encounter warnings about their unhealthy 
behavior 
Behavioral Processes (generally used in later stages of change) 
Stimulus Control Making changes in one’s environment to 
support behavior change 
Counter Conditioning Substituting new behaviors for the 
problematic behavior that one is working to 
change 
Reinforcement Management Rewarding oneself for not engaging in the 
target behavior 
Helping Relationships Identifying relationships in one’s life that 
are supportive of the behavior change 
Self-Liberation The belief that one can change and 
committing to make a change 
Note. Velasquez, Crouch, Stephens, & DiClemente, 2016; Velicer, Prochaska, Fava, 
Norman, & Redding, 1998. 
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Table 2 
Sociodemographic Characteristics of Participants 
Characteristics	 All	Clients	 TTM	Group	 Ed-Advice	
Race/Ethnicity	
Latino	 8.3%	 7.8%	 9.1%	
Black	 72.2%	 71.9%	 72.7%	
White	 19.4%	 20.3%	 18.2%	
Gender	
Female	 24.4%	 17.2%	 25.0%	









Employed	 40.2%	 45.3%	 32.6%	
Not	Employed	 52.3%	 48.4%	 58.1%	
Not	in	Workforce	 7.5%	 6.3%	 9.3%	
Income	
<$5,000	 36.1%	 40.6%	 29.5%	
$5,000-19,999	 31.5%	 29.8%	 34.0%	
$20,000-29,000	 15.7%	 10.9%	 22.7%	
$30,000+	 16.7%	 18.7%	 13.8%	
Homeless	
Yes	 38.9%	 42.2%	 34.1%	
Note. TTM =transtheoretical model of change; Ed-Advice=Education/Advice (Control 
Group); HS=high school; GED=General Education Development test. 
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Descriptive Statistics of Depressive Symptoms Subscale and Global Severity Index of the 
Brief Symptom Inventory at Intake and Post-treatment 
 
  Mean Standard 
Deviation 
Minimum Maximum 
Intake      
 Depression Subscale 1.247 .894 0 3.83 
 Global Severity Index 
 
1.016 .689 0 3.82 
Post-treatment      
 Depression Subscale .969 1.761 0 16.50 
 Global Severity Index .692 .696 0 2.62 
Note. Scores derive from a Likert scale ranging from zero to four measuring how much 










 Intake Post-Treatment Follow-up 
 M SD M SD M SD 
Experiential Processes       
Consciousness Raising 3.691 .973 3.914 .819 3.892 1.025 
Self-Reevaluation 3.953 .814 3.805 .826 3.742 1.025 
Social Liberation 
(Experiential) 
3.178 .990 3.484 .912 3.265 1.116 
Environmental 
Reevaluation 
3.765 .942 3.875 .769 3.729 1.040 
Dramatic Relief 3.524 .860 3.474 .829 3.335 .948 
       
Behavioral Processes       
Stimulus Control 3.044 .966 3.644 .971 3.596 1.118 
Counter Conditioning 3.168 .865 3.620 .919 3.565 1.030 
Reinforcement 
Management 
2.896 .977 3.433 1.066 3.317 1.070 
Helping Relationships 2.936 1.054 3.417 1.066 3.381 1.140 
Self-Liberation  3.101 .944 3.660 .980 3.654 1.109 
Social Liberation 
(Behavioral) 
2.943 .963 3.346 .974 3.265 1.037 
Note. Scores derive from a Likert scale measuring frequency of use ranging from one to 









 Intake Post-Treatment Follow-up 
 M SD M SD M SD 
Experiential Processes 3.647 .674 3.750 .670 3.649 .858 
Behavioral Processes 3.014 .696 3.520 .862 3.462 .949 
Temptation 3.086 .838 2.558 .949 2.583 1.041 
Confidence 2.668 .818 2.962 .994 3.130 1.081 
Decisional Balance - 
Pros 
3.615 1.087 3.662 1.069 3.723 1.126 
Decisional Balance - 
Cons 
2.105 .950 2.280 .961 2.311 1.088 
Precontemplation 2.0331 .795 2.262 .853 2.091 .718 
Contemplation 4.435 .578 4.018 .578 3.993 .845 
Action 4.203 .568 3.908 .726 3.856 .868 
Note. Scores derive from Likert scales ranging from one to five, where one indicates a 






Intake Post-Treatment Follow-up 
M SD M SD M SD 
Experiential Processes 
Consciousness Raising 
Depressed 3.780 .945 3.960 .703 4.123 .818 
Not Depressed 3.662 .952 3.870 .895 3.700 1.110 
Self-Reevaluation 
Depressed 3.968 .623 3.873 .806 4.100 .834 
Not Depressed 3.836 .885 3.751 .846 3.514 1.083 
Social Liberation (Experiential) 
Depressed 3.122 .829 3.508 .859 3.456 .840 
Not Depressed 3.261 1.041 3.469 .957 3.197 1.233 
Environmental Reevaluation 
Depressed 3.829 .934 4.016 .694 4.061 .782 
Not Depressed 3.594 .972 3.763 .802 3.481 1.121 
Dramatic Relief 
Depressed 3.537 .767 3.548 .782 3.531 .771 
Not Depressed 3.401 .946 3.429 .828 3.240 1.044 
Behavioral Processes 
Stimulus Control 
Depressed 3.106 .880 3.524 .952 3.684 1.040 
Not Depressed 3.039 1.050 3.706 .977 3.495 1.173 
Counter Conditioning 
Depressed 3.114 .791 3.492 .807 3.754 .899 
Not Depressed 3.174 .870 3.686 .960 3.459 1.102 
Reinforcement Management 
Depressed 2.675 1.029 3.143 1.090 3.211 1.061 
Not Depressed 3.053 .930 3.655 .998 3.404 1.096 
Helping Relationships 
Depressed 2.732 .970 3.333 1.136 3.303 1.082 
Not Depressed 3.159 1.040 3.435 1.021 3.421 1.186 
Self-Liberation 
Depressed 3.024 .944 3.611 .957 3.737 1.091 
Not Depressed 3.106 .963 3.684 .980 3.552 1.125 
Social Liberation (Behavioral) 
Depressed 2.951 .848 3.341 .900 3.254 .947 
Not Depressed 2.952 .992 3.339 1.039 3.257 1.084 
Note. Scores derive from a Likert scale measuring frequency of use ranging from one to 








 Intake Post-Treatment Follow-up 
 M SD M SD M SD 
Experiential Processes      
Depressed 3.696 .588 3.822 .589 3.904 .651 
Not Depressed 3.570 .734 3.696 .713 3.478 .951 
Behavioral Processes       
Depressed 2.932 .632 3.407 .819 3.489 .873 
Not Depressed 3.081 .748 3.584 .885 3.431 1.017 
Temptation        
Depressed 3.372 .730 2.834 .854 2.710 .909 
Not Depressed 2.887 .838 2.370 .980 2.508 1.107 
Confidence       
Depressed 2.641 .854 2.875 .900 3.134 1.029 
Not Depressed 2.670 .836 3.009 1.072 3.196 1.097 
Decisional Balance - Pros     
Depressed 3.532 1.101 3.611 .844 3.937 1.009 
Not Depressed 3.630 1.059 3.683 1.232 3.612 1.181 
Decisional Balance - Cons      
Depressed 2.091 .903 2.143 .778 2.320 1.083 
Not Depressed 2.210 1.024 2.444 1.042 2.359 1.100 
Precontemplation        
Depressed 2.143 .915 2.250 .817 2.082 .635 
Not Depressed 2.036 .774 2.292 .876 2.140 .755 
Contemplation         
Depressed 4.432 .455 4.120 .595 3.907 .840 
Not Depressed 4.397 .608 3.932 .924 4.009 .857 
Action       
Depressed 4.238 .527 3.932 .645 3.707 .920 
Not Depressed 4.150 .595 3.874 .775 3.879 .831 
Note. Scores derive from Likert scales ranging from one to five, where one indicates a 










Figure 1. Processes of change that mediate progression between the stages of change 
according to the transtheoretical model of change (figure taken from Prochaska, Redding, 





Figure 2. An example of profile analysis of drinking-outcome-related differences across 







Figure 3. Processes of change of participants with and without elevated depressive 
symptoms at intake (profiles did not significantly deviate from parallelism at the .05 
level). CR = consciousness raising; SR = self-reevaluation; SocL Exp = social liberation 
experiential; ER = environmental reevaluation; DR = dramatic relief; SC = stimulus 
control; CC = counter conditioning; RM = reinforcement management; HR = helping 






Figure 4. Processes of change of participants with and without elevated depressive 
symptoms at post-treatment (profiles did significantly deviate from parallelism at the .05 
level). CR = consciousness raising; SR = self-reevaluation; SocL Exp = social liberation 
experiential; ER = environmental reevaluation; DR = dramatic relief; SC = stimulus 
control; CC = counter conditioning; RM = reinforcement management; HR = helping 






Figure 5. Processes of change of participants with and without elevated depressive 
symptoms at the three-month follow-up (profiles did significantly deviate from 
parallelism at the .05 level).  CR = consciousness raising; SR = self-reevaluation; SocL 
Exp = social liberation experiential; ER = environmental reevaluation; DR = dramatic 
relief; SC = stimulus control; CC = counter conditioning; RM = reinforcement 
management; HR = helping relationships; SL = self-liberation; SocL Beh = social 






Figure 6. Transtheoretical model variables of participants with and without elevated 
depressive symptoms at intake (profiles did not significantly deviate from parallelism at 
the .05 level). Exp Pro = experiential processes; Beh Pro = behavioral processes; Tempt = 
temptation; Conf = confidence; Pros = pros of change; Cons = cons of change; Precont = 






Figure 7. Transtheoretical model variables of participants with and without elevated 
depressive symptoms at post-treatment (profiles did not significantly deviate from 
parallelism at the .05 level).  Exp Pro = experiential processes; Beh Pro = behavioral 
processes; Tempt = temptation; Conf = confidence; Pros = pros of change; Cons = cons 
of change; Precont = precontemplation stage; Cont  =contemplation stage; Act = action 






Figure 8. Transtheoretical model variables of participants with and without elevated 
depressive symptoms at three-month follow-up (profiles did significantly deviate from 
parallelism at the .05 level).  Exp Pro = experiential processes; Beh Pro = behavioral 
processes; Tempt = temptation; Conf = confidence; Pros = pros of change; Cons = cons 
of change; Precont = precontemplation stage; Cont  =contemplation stage; Act = action 






Figure 9. Percent daily use of cocaine at each time point by treatment condition.  The 






Methodology of Feasibility Study (Velasquez, Stotts, von Sternberg, Dodrill, & 
Sampson, not yet published)
Participants 
The study was conducted at a university-based outpatient substance use disorders 
clinic. Recruitment methods included newspaper ads, radio ads, flyers, brochures and 
letters sent to professionals indicating that outpatient treatment was available. The 
intervention trial recruited and enrolled 138 participants and assigned them to the TTM 
intervention condition (n=82) or the Ed-Advice comparison condition (n=56)(see consort 
chart-Figure 1). We originally proposed four 12-session groups for each condition. 
However, given sufficient resources and our particular interest in the study aim “To 
assess the effect of the TTM group therapy on the proposed mechanisms of change,” we 
ran two additional TTM groups for a total of 6 TTM groups and 4 Ed-Advice groups.  
Eligible participants were over 18 and met DSM-IV criteria for cocaine abuse or 
dependence.  Participants completed an intake assessment that included detailed 
information about the study, demographic information, personal history and degree of 
cocaine and other substance use. Each intake cohort was assigned together to the next 
available group within 33 days of their completed intake (on average, group began 13 
days after participant intake).  
Design and Procedure 
The primary aims were 1) to modify the Group Treatment for Substance Abuse: A 
Stages-of-Change Therapy Manual to specifically target cocaine abuse, resulting in a 
twelve-session, group intervention and accompanying therapy manual based on the TTM 
stages and processes of change, 2) to develop the parallel training program and training 
materials for therapists, and 3) to train therapists to deliver the intervention. The stage 1b 
primary aim was to conduct a preliminary trial with cocaine abusing participants 
comparing the TTM group therapy to an education/advice comparison group. This pilot 
study was designed to a) demonstrate the feasibility of delivering the TTM group therapy 
with masters-level mental health professionals; b) determine acceptance of the TTM 
group therapy as measured by client adherence, retention, and treatment satisfaction; c) 
assess participant improvement over the course of treatment (e.g., drug use). Additional 
aims of stage 1b were to assess the effect of the TTM group therapy on the proposed 
mechanisms of change, thereby testing whether a) TTM group therapy increases 
processes of change use compared to the comparison group; b) increased process use 
promotes stage of change movement; and c) process use and stage movement enhance 
retention and diminish drug use. Finally, we proposed to measure motivation (i.e., stage 
of change) and determine whether there is differential outcome for those in early vs. late 
stages of change thus providing valuable information regarding matching (and mis-
matching) motivation with treatment.   
The study successfully accomplished all phases of the originally proposed 
research. First, a TTM intervention manual was created specifically for the study 
population by modifying the existing Group Treatment for Substance Abuse: A Stages-of-
Change Therapy Manual by  




0-7 Day Post Treatment Assessment 
37 (66%) Completed 
 
0-7 Day Post Treatment Assessment 
57 (70%) Completed 
3 Month Post Treatment Assessment 
55 (67%) Completed 
3 Month Post Treatment Assessment 
37 (66%) Completed 
138 Assigned to Conditions 
56 allocated to Education/Advice 
intervention 
44 received tx (at least one session) 
  (1 withdrew after attending some) 
  11 did not receive any treatment 
 
82 allocated to TTM intervention 
64 received tx (at least one session) 
  (1 withdrew after attending some) 
 17 did not receive any treatment 
    
 
61 Excluded at Intake (assigned an ID but not randomized) 
    Of these 61: 
    53  were Ineligible at intake (some met multiple exclusion criteria) 
         16 – major depression  23 – phys. alcohol dependence 
         10 – other drug dependence  1 – no cocaine abuse/dep 
          2 – no cocaine use in 30 days 2 – unable to comprehend/read 
          2 – treatment/rsch within 6 months 2  declined participation after intake 
          2 – psychotic diagnosis  1 - seizures 
      
     8 - did not complete intake      
     
153 – Did not show up to intake appointment or did not sign consent form 
 
513 screened for eligibility by phone 
73 Excluded at phone screen 
 26 – psychiatric medication or diagnosis 11 – treatment within past 6 months 
 19 – no cocaine use in past 30 days 2 – cannot read/understand English 
 14 – polysubstance abuse   1 – no stable residence 
 
88 Uninterested at phone screen 
   7 – schedule conflict for intake  10 – could not contact to set up intake 
 15 – schedule conflict for group  6 – wanted inpatient treatment 
 50 – otherwise not interested             
 
















































 Velasquez et al. (2001) into a 12-session group therapy intervention for cocaine 
use.  Development of the cocaine-specific 12 session manual was informed by focus 
groups of recovering cocaine users and an advisory panel composed of researchers and 




advisory panel reviewed the modifications of the original treatment manual with special 
attention to feedback from the focus groups. The result was a 12 session (six experiential 
POC sessions and six behavioral POC sessions) cocaine group treatment. The reduced 
number of sessions allowed us to offer a relatively brief yet comprehensive intervention 
that targets each of the TTM processes of change.    
Both the TTM groups and the Ed-Advice groups were closed groups that met twice a 
week for six weeks for a total of twelve 90-minute sessions. Each week, participants 
provided a urine sample and completed scheduled measures. Participants received a small 
stipend ($10) for each session they attended. All sessions were videotaped. After each 
session, therapists wrote a session summary and completed a Therapist Treatment 
Evaluation form which described their perceptions of participant 
involvement/satisfaction. They also completed a session feedback form (Therapist 
Feedback) about the session activities, and a session checklist, which served as a measure 
of therapist competence and treatment adherence. All videotapes were reviewed by Drs. 
Velasquez or Stotts to assure treatment fidelity. All therapists received weekly 
supervision throughout.  
Measures administered in the study gathered information about demographics, 
diagnoses, participant substance use, psychiatric status, and psychosocial functioning. 
TTM measures assessed experiential and behavioral POC, readiness for change, 
temptation, confidence, and decisional balance. Clients and therapists also completed 
measures on treatment satisfaction, adherence, therapeutic alliance, and group cohesion. 
some measures were administered at each session, some each week and others at intake, 




 The TTM groups followed the adapted treatment manual intervention. The first 
six sessions focused on the experiential POC and the last six addressed the behavioral 
POC. The TTM groups were co-facilitated by two experienced therapists. Four master’s 
and doctoral-level therapists served as co-facilitators over the course of the study. The 
same clinicians conducted each of the twelve sessions for each cohort. Prior to leading 
the groups, all therapists thoroughly reviewed the manual and met twice with the PI and 
other research team members for implementation training. Training included detailed 
instruction on the intervention and treatment protocol, training in TTM with an emphasis 
on the POC, role plays and practice.  
  The Ed-Advice group followed a manualized intervention focused on traditional 
outpatient treatment strategies to build skills for successfully reducing cocaine use. This 
intervention utilized educational materials that are typically used in traditional substance 
abuse treatment.  Sessions included both didactic and discussion components in which 
clients were introduced to the materials and then discussed how the information applied 
to their cocaine use. Clients were encouraged to attend twelve-step meetings but these 
meetings were not discussed in depth during group sessions.  Session content included: 
an introduction to the biopsychosocial model of addiction and symptoms associated with 
cocaine use; defense mechanisms; social support; effects of cocaine on the brain; the 
disease model; negative consequences; stages of recovery; nutrition; codependency; HIV 
and cocaine abuse; and job finding strategies.   
The Ed-Advice group was delivered by experienced masters and doctoral level 
therapists over 12 sessions. Similar to training for the TTM condition, prior to leading the 
groups all therapists thoroughly reviewed the manual and met twice with the PI and other 
research team members for training. Training included instructions on delivering the 
material in a didactic style and on allowing discussion of the materials. The PI provided 





 In sum, the primary aims of a stage I pilot study were to determine the feasibility, 
acceptance and promise of a newly-developed behavioral intervention. Consistent with 
the specific aims of our original study, we modified the newly-developed treatment 
manual to specifically target cocaine abuse, developed the parallel training program and 
materials for therapists, and trained master’s and doctoral level therapists to deliver the 
intervention. As detailed below, we then conducted a pilot study which demonstrated the 
feasibility of delivery of the manualized intervention, determined acceptance of the TTM 
group therapy and assessed participant improvement over the course of treatment. We 
further assessed the effect of the intervention on process use and cocaine use and 









BRIEF SYMPTOM INVENTORY 
          
 
There are five possible responses to each of the items in this questionnaire: 
 
     0 - Not at all 
     1 - A little bit 
     2 - Moderately 
     3 - Quite a bit 
     4 - Extremely 
 
Please circle the number that indicates how much you are currently (last 7 days) 
distressed by each of the following: 
 
  Not at  
all 




Quite a  
bit 
Extremely 
       
1. Nervousness or shakiness 
inside 
0 1 2 3 4 
       
2. Faintness or dizziness 0 1 2 3 4 
       
3. The idea that someone 
else can control your 
thoughts 
0 1 2 3 4 
       
4. Feeling others are to 
blame for most of your 
troubles 
0 1 2 3 4 
       
5. Trouble remembering 
things 
0 1 2 3 4 
       
6. Feeling easily annoyed or 
irritated 
0 1 2 3 4 
       
7. Pains in heart or chest 0 1 2 3 4 
       
8. Feeling afraid in open 
spaces or on the streets 
0 1 2 3 4 
       
9. Thoughts of ending your 
life 
0 1 2 3 4 
       
10. Feeling that most people 
cannot be trusted  
0 1 2 3 4 
       







Not at  
all 
 










       
12. Suddenly scared for no 
reason 
0 1 2 3 4 
       
13. Temper outbursts that 
you could not control 
0 1 2 3 4 
       
14. Feeling lonely even when 
you are with people 
0 1 2 3 4 
       
15. Feeling blocked in getting 
things done 
0 1 2 3 4 
       
16. Feeling lonely 0 1 2 3 4 
       
17. Feeling blue 0 1 2 3 4 
       
18. Feeling no interest in 
things 
0 1 2 3 4 
       
19. Feeling fearful 0 1 2 3 4 
       
20. Your feelings being easily 
hurt 
0 1 2 3 4 
       
21. Feeling that people are 
unfriendly or dislike you 
0 1 2 3 4 
       
22. Feeling inferior to others 0 1 2 3 4 
       
23. Nausea or upset stomach 0 1 2 3 4 
       
24. Feeling that you are 
watched or talked about 
by others 
0 1 2 3 4 
       
25. Trouble falling asleep 0 1 2 3 4 
       
26. Having to check and 
double-check what you do 
0 1 2 3 4 
       
27. Difficulty making decisions 0 1 2 3 4 
       
28. Feeling afraid to travel on 




1 2 3 4 




  Not at  
all 














1 2 3 4 
       
30. Hot or cold spells 0 1 2 3 4 
       
       
31. Having to avoid certain 
things, places or activities 
because they frighten you 
0 1 2 3 4 
       
32. Your mind going blank 0 1 2 3 4 
       
33. Numbness or tingling in 
parts of your body 
0 1 2 3 4 
       
34. The idea that you should 
be punished for your sins 
0 1 2 3 4 
       
35. Feeling hopeless about 
the future 
0 1 2 3 4 
       
36. Trouble concentrating 0 1 2 3 4 
       
37. Feeling weak in parts of 
your body 
0 1 2 3 4 
       
38. Feeling tense or keyed up 0 1 2 3 4 
       
39. Thoughts of death or 
dying 
0 1 2 3 4 
       
40. Having urges to beat, 
injure, or harm someone 
0 1 2 3 4 
       
41. Having urges to break or 
smash things 
0 1 2 3 4 
       
42. Feeling very self-
conscious with others 
0 1 2 3 4 
       
43. Feeling uneasy in crowds, 
such as shopping or at a 
movie 
0 1 2 3 4 
       
44. Never feeling close to 
another person 
0 1 2 3 4 




  Not at 
all 







45. Spells of terror or panic 0 
 
1 2 3 4 
       
46. Getting into frequent 
arguments 
0 1 2 3 4 
       
47. Feeling nervous when you 
are left alone 
0 1 2 3 4 
       
48. Others not giving you 
proper credit for your 
achievements 
0 1 2 3 4 
       
49. Feeling so restless you 
couldn't sit still 
0 1 2 3 4 
       
50. Feelings of worthlessness 0 1 2 3 4 
       
51. Feeling that people will 
take advantage of you if 
you let them 
0 1 2 3 4 
       
52. Feelings of guilt 0 1 2 3 4 
       
53. The idea that something 
is wrong with your mind 
0 1 2 3 4 
















PROCESSES OF CHANGE  
 
This questionnaire is designed to give us a better understanding of what strategies you have 
used to help yourself to not use cocaine.  Each statement describes a situation or thought that a 
person might try to help them not use cocaine.  Please indicate how often you experience or do 
any of the following to help you avoid using cocaine.   
 
1. I realize that when I am using cocaine I am not the person I want to be.   
1. Never 
2. Seldom  




2. I stop to think about how my cocaine use has affected my family, work and social life.  
1. Never 
2. Seldom  




3. Keeping myself busy reduces my craving for cocaine. 
1. Never 
2. Seldom  




4. I avoid people I’ve used cocaine with. 
1. Never 
2. Seldom  




5. When tempted to use cocaine, I try to distract myself by doing something else. 
1. Never 
2. Seldom  







6. I have someone who listens when I need to talk about my cocaine use. 
1. Never 
2. Seldom  




7. I see advertisements or hear reports about how society wants people to be drug free. 
1. Never 
2. Seldom  





8. I find ways to reward myself for not using cocaine.  
1. Never 
2. Seldom  




9. I am ashamed of some of the things I’ve done while using cocaine. 
1. Never 
2. Seldom  




10. There is someone in my life who tries to make me feel good for staying off cocaine. 
1. Never 
2. Seldom  




11.  I seek out places to get help when I need it. 
1. Never 
2. Seldom  









2. Seldom  




13. I see signs in public places that tell people not to use drugs like cocaine. 
1. Never 
2. Seldom  




14. I have learned that cocaine may cause serious emotional problems. 
1. Never 
2. Seldom  




15. I stop and think that my cocaine use is causing problems for other people. 
1. Never 
2. Seldom  




16. I am disappointed in myself when I turn to cocaine.  
1. Never 
2. Seldom  




17. It frightens me when I think of situations I have found myself in because of cocaine. 
1. Never 
2. Seldom  









2. Seldom  




19. I avoid places where people are using cocaine. 
1. Never 
2. Seldom  




20. I look for people who will support and care about me in my attempts to change.  
1. Never 
2. Seldom  




21. I do something nice for myself when I don’t give in to my urge to use cocaine.  
1. Never 
2. Seldom  




22. I have become more aware of the dangers of using cocaine. 
1. Never 
2. Seldom  




23. I make commitments to myself to stay away from cocaine.   
1. Never 
2. Seldom  




24. The strength of my cravings for cocaine frightens me. 
1. Never 








25.  I look for resources in the community that can help me avoid using cocaine. 
1. Never 
2. Seldom  
3. Occasionally  
4. Frequently 
5. Repeatedly 
26.  I set goals for myself to stay off cocaine no matter how hard it is.  
 
1. Never 
2. Seldom  




27. Stories about the dangers of cocaine affect me emotionally. 
1. Never 
2. Seldom  




28. I stay away from things (triggers) associated with my cocaine use. 
1. Never 
2. Seldom  




29. I notice more people saying they don’t want to be pressured to use cocaine anymore. 
1. Never 
2. Seldom  




30. I have come to understand that serious medical problems may result from cocaine use. 
1. Never 
2. Seldom  







31. I act on my plan to stay cocaine free. 
1. Never 
2. Seldom  




32. I have someone I can count on when I’m having cocaine-related problems. 
1. Never 
2. Seldom  




33.  I am focusing on the areas of my life that I have neglected because of my cocaine use. 
1. Never 
2. Seldom  






















Listed below are a number of situations that lead some people to use 
cocaine. We would like to know how tempted you would be to use cocaine 
in each of these situations. 
 
Choose the response that best describes the feelings of temptation you 
have for each situation, at the present time, according to the following 
scale: 
 
1 Not at all tempted 
2 Not very tempted 
3 Moderately tempted 
4 Very tempted 
5 Extremely tempted 
 
Again we want to know how tempted you are at the present time, that you 
would use cocaine on each of these situations. 
 
Situation        How Tempted 
 
1. When I am craving cocaine. 1 2 3 4 5 
2.  When my body is aching. 1 2 3 4 5 
3.  When I am feeling depressed. 1 2 3 4 5 
4. When I want to relax. 1 2 3 4 5 
5. When someone disappoints me or lets me down. 1 2 3 4 5 
6.  When I am very worried. 1 2 3 4 5 
7. When I have the urge to try one hit of cocaine to see 
what happens. 
1 2 3 4 5 
8. When someone offers me cocaine. 1 2 3 4 5 
9.  When I dream about taking a hit of cocaine. 1 2 3 4 5 
10.  When I want to test my will power over using 
cocaine. 
1 2 3 4 5 
11.  When I am feeling a physical need or craving for 
cocaine. 




12.  When I am physically tired. 1 2 3 4 5 
13.  When I feel some physical pain or injury. 1 2 3 4 5 
14.  When I feel like blowing up because of frustration. 1 2 3 4 5 
15.  When I see others using or buying cocaine. 
 
1 2 3 4 5 
16.  When I sense that everything is going wrong for me. 1 2 3 4 5 
17.  When people I used to use cocaine with encourage 
me to use cocaine. 
1 2 3 4 5 
18.  When I am feeling angry inside. 1 2 3 4 5 
19. When I have an urge to use cocaine that catches me 
unprepared. 
1 2 3 4 5 
20.  When I am excited or celebrating with others.  1 2 3 4 5 
21. When I think about the last time I got high. 1 2 3 4 5 
22.  When someone hurts my feelings. 1 2 3 4 5 
23.  When I think about my first hit of cocaine. 1 2 3 4 5 
24.  When I get money. 1 2 3 4 5 
25.  When I see someone I used to use cocaine with. 1 2 3 4 5 
26.  When I’m feeling bored. 1 2 3 4 5 
27.  When I pass by the neighborhood that I used 
cocaine in. 
1 2 3 4 5 
28.  After I’ve had enough alcohol. 1 2 3 4 5 
29.  When I’m feeling lonely. 1 2 3 4 5 
30.  When it’s the weekend. 1 2 3 4 5 













Listed below are a number of situations that lead some people to use 
cocaine. We would like to know how confident you are that you would NOT 
use cocaine in each of these situations. 
 
Choose the response that best describes the feelings of confidence you 
have for each situation, at the present time, according to the following 
scale: 
 
1 Not at all confident 
2 Not very confident 
3 Moderately confident 
4 Very confident 
5 Extremely confident 
 
Again we want to know how confident you are at the present time, that you 
would NOT use cocaine on each of these situations. 
 
Situation        How Confident 
 
1. When I am craving cocaine. 1 2 3 4 5 
2.  When my body is aching. 1 2 3 4 5 
3.  When I am feeling depressed. 1 2 3 4 5 
4. When I want to relax. 1 2 3 4 5 
5. When someone disappoints me or lets me down. 1 2 3 4 5 
6.  When I am very worried. 1 2 3 4 5 
7. When I have the urge to try one hit of cocaine to see 
what happens. 
1 2 3 4 5 
8. When someone offers me cocaine. 1 2 3 4 5 
9.  When I dream about taking a hit of cocaine. 1 2 3 4 5 
10.  When I want to test my will power over using 
cocaine. 
1 2 3 4 5 
11.  When I am feeling a physical need or craving for 
cocaine. 
1 2 3 4 5 




13.  When I feel some physical pain or injury. 1 2 3 4 5 
14.  When I feel like blowing up because of frustration. 1 2 3 4 5 
15.  When I see other using or buying cocaine. 
 
1 2 3 4 5 
16.  When I sense that everything is going wrong for me. 1 2 3 4 5 
17.  When people I used to use cocaine with encourage 
me to use cocaine. 
1 2 3 4 5 
18.  When I am feeling angry inside. 1 2 3 4 5 
19. When I have an urge to use cocaine that catches me 
unprepared. 
1 2 3 4 5 
20.  When I am excited or celebrating with others.  1 2 3 4 5 
21. When I think about the last time I got high. 1 2 3 4 5 
22.  When someone hurts my feelings. 1 2 3 4 5 
23.  When I think about my first hit of cocaine. 1 2 3 4 5 
24.  When I get money. 1 2 3 4 5 
25.  When I see someone I used to use cocaine with. 1 2 3 4 5 
26.  When I’m feeling bored. 1 2 3 4 5 
27.  When I pass by the neighborhood that I used 
cocaine in. 
1 2 3 4 5 
28.  After I’ve had enough alcohol. 1 2 3 4 5 
29.  When I’m feeling lonely. 1 2 3 4 5 
30.  When it’s the weekend. 1 2 3 4 5 















PROS AND CONS: The following statements represent different opinions about cocaine.  Please 
rate HOW IMPORTANT each statement is to you in deciding whether or not to use cocaine 
according to the following 5 point scale with 1 = Extremely important and 5 = Not important. 
 
1. I feel better about my self while using cocaine.  
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
2. Cocaine makes me feel more confident and sociable. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
3. I am more fun to be with when I use cocaine. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important  
 
4. My cocaine use has led me to act irresponsibly. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
5. I feel more confident when I use cocaine. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
6. When using cocaine I fail to keep up with bills. 




2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
7. Cocaine helps me relieve tension. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
8. As I became more involved with cocaine, I pulled away from people I was once close to. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
9. When using cocaine, I borrow money, which I fail to pay back. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
10. Cocaine gives me that extra boost of energy. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
11. Buying cocaine has contributed to my experiencing some financial strain. 
1. Extremely important 
2. Quite important  
3. Somewhat important  
4. A little bit important 
5. Not important 
 
12. I experience sleep problems when I use cocaine. 
1. Extremely important 




3. Somewhat important  
4. A little bit important 







University of Rhode Island Change 
Assessment 
   Follow-Up Version (URICA-F) 
    
       
         Each statement below describes how a person might feel when approaching problems 
related to  
 cocaine use in their lives. Please indicate the extent to which you tend to agree or disagree with 
each 
statement. In each case, make your choice in terms of how you feel RIGHT NOW, not 
what you 
 have felt in the past or would like to feel. 
     
          
          There are FIVE possible responses to each of the items in the questionnaire: 
    
       1 = Strongly Disagree 
   
    
       2 =  Disagree 
    
    
       3 = Undecided 
    
    
       4 = Agree 
    
    
       5 = Strongly Agree 
    
          
          Circle the number that best describes how much you agree or disagree with each 
statement. 
 
                    Strongly Disagree Undecided Agree Strongly           Disagree Agree 
1. 
As far as I'm concerned, I don't 
have any problems with cocaine 
that need changing.   
1 2 3 4 5 
2. 
I think I might be ready for some 
self-improvement. 1 2 3 4 5 
3. 
I am doing something about the 
problems with cocaine that had 
been bothering me.  
1 2 3 4 5 
4. 
It might be worthwhile to work on 
my problem with cocaine. 1 2 3 4 5 
5. 
I'm not the problem one. It doesn't 
make much sense for me to 
consider changing. 
1 2 3 4 5 
6. 
It worries me that I might slip back 
on a problem with cocaine I have 
already changed so I am looking 
for help.   
1 2 3 4 5 
7. 
I am finally doing some work on my 
problem with cocaine. 1 2 3 4 5 
8. 
I've been thinking that I might want 
to change something about myself.  1 2 3 4 5 
9. 
I have been successful in working 
on my problem with cocaine but I’m 
not sure I can keep up the effort on 
my own.  





At times my problem with cocaine 
is difficult, but I’m working on it.  1 2 3 4 5 
11. 
Trying to change is pretty much a 
waste of time for me because the 
problem with cocaine doesn't have 
to do with me.  
1 2 3 4 5 
12. 
I'm hoping that I will be able to 
understand myself better.  1 2 3 4 5 
13. 
I guess I have faults, but there's 
nothing that I really need to 
change.  
1 2 3 4 5 
14. I am really working hard to change. 1 2 3 4 5 
15. 
I have a problem with cocaine and 
I really think I should work on it.  1 2 3 4 5 
16. 
I'm not following through with what 
I had already changed as well as I 
had hoped, and I want to prevent a 
relapse of the problem with 
cocaine. 
1 2 3 4 5 
17. 
Even though I'm not always 
successful in changing, I am at 
least working on my problem with 
cocaine.   
1 2 3 4 5 
18. 
I thought once I had resolved the 
problem with cocaine I would be 
free of it, but sometimes I still find 
myself struggling with it.   
1 2 3 4 5 
19. 
I wish I had more ideas on how to 
solve my problem with cocaine.   1 2 3 4 5 
20. 
I have started working on my 
problem with cocaine but I would 
like help.   
1 2 3 4 5 
21. 
Maybe someone or something will 
be able to help me.   1 2 3 4 5 
22. 
I may need a boost right now to 
help me maintain the changes I’ve 
already made.   
1 2 3 4 5 
23. 
I may be part of the problem with 
cocaine but I don’t really think I am.   1 2 3 4 5 
24. 
I hope that someone will have 
some good advice for me. 1 2 3 4 5 
25. 
Anyone can talk about changing; 
I'm actually doing something about 
it.   
1 2 3 4 5 
26. 
All this talk about psychology is 
boring. Why can't people just forget 
about their problems? 
1 2 3 4 5 
27. 
I'm struggling to prevent myself 
from having a relapse of my 
problem with cocaine.   
1 2 3 4 5 
28. 
It is frustrating, but I feel I might be 
having a recurrence of a problem 
with cocaine I thought I had 
resolved. 
1 2 3 4 5 




guy. Why spend time thinking 
about them? 
30. 
I am actively working on my 
problem with cocaine 1 2 3 4 5 
31. 
I would rather cope with my faults 
than try to change them.  1 2 3 4 5 
32. 
After all I had done to try and 
change my problem with cocaine, 
every now and again it comes back 
to haunt me. 










    
      Sunday Monday Tuesday Wednesday Thursday Friday Saturday 
Super Bowl    1 Groundhog    2 3 4 5 6 7 
C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N 
8 9 10 11 
Lincoln Bday    
12 13 
Valentines   
14 
C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N 
15 President's Day  16 17 18 19 20 21 
C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N 
22 23 24 Ash Wed     25 26 27 28 
C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N C:   Y        N 
29             
C:   Y        N             




  Notes: ___________________________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
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